Podcasts about schering plough

Join Dr. Mario Castro and Prof. Vibeke Backer as they discuss airway remodeling and airway hyperresponsiveness and their impact in the lives of patients with severe asthma. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com.   This podcast is intended for healthcare professionals only.   Disclaimer: This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. Speaker disclosures: Mario Castro, MD, MPH, reports grants and research support from NIH, ALA, PCORI, AstraZeneca, Gala Therapeutics, Genentech, GSK, Novartis, Pulmatrix, Sanofi-Aventis, Shionogi, and Theravance. He receives consulting fees from Genentech, Teva, Sanofi-Aventis, Merck, Novartis, Arrowhead Pharmaceuticals, Allakos, Amgen, OM Pharma, Pfizer, Pioneering Medicines, and GSK. He receives payment for speaker bureau activities from Amgen, AstraZeneca, Genentech, Regeneron, Sanofi-Aventis, and Teva. He also receives stock options from Aer Therapeutics. Vibeke Backer, MD, has worked as an advisor, supervisor, and investigator of pharmaceutical studies and has received unrestricted grants from AstraZeneca, GSK, MSD & Schering Plough, ALK-Abelló, Nycomed, Chiesi, Novartis, Pharmaxis, Nigaard, Pfizer, Boehringer Ingelheim, Maribo Medico, Aerocrine, Teva, Sanofi, Regeneron, and BIRK NPC. © 2024 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2401489 – 1.0 – 10/2024 MAT-US-2410093 v1.0 – P Expiration Date: 10/09/2026

rWotD Episode 2669: ViroPharma Welcome to Random Wiki of the Day, your journey through Wikipedia’s vast and varied content, one random article at a time.The random article for Saturday, 24 August 2024 is ViroPharma.ViroPharma Incorporated was a pharmaceutical company that developed and sold drugs that addressed serious diseases treated by physician specialists and in hospital settings. The company focused on product development activities on viruses and human disease, including those caused by cytomegalovirus (CMV) and hepatitis C virus (HCV) infections. It was purchased by Shire in 2013, with Shire paying around $4.2 billion for the company in a deal that was finalized in January 2014. ViroPharma was a member of the NASDAQ Biotechnology Index and the S&P 600.The company had strategic relationships with GlaxoSmithKline, Schering-Plough, and Sanofi-Aventis. ViroPharma acquired Lev Pharmaceuticals in a merger in 2008.This recording reflects the Wikipedia text as of 00:01 UTC on Saturday, 24 August 2024.For the full current version of the article, see ViroPharma on Wikipedia.This podcast uses content from Wikipedia under the Creative Commons Attribution-ShareAlike License.Visit our archives at wikioftheday.com and subscribe to stay updated on new episodes.Follow us on Mastodon at @wikioftheday@masto.ai.Also check out Curmudgeon's Corner, a current events podcast.Until next time, I'm neural Matthew.

On this episode of The Vitamin Professor Podcast, Professor Gene Bruno talks to Michael Anthonavage of Vitaquest International. Michael Anthonavage currently serves as the VP of Innovation at Vitaquest International, dedicated to expanding the supplement market footprint and ensuring customers gain a competitive edge. Michael has expertise in bringing new technologies to the market, championing innovation and growth for all areas of health and nutrition as well as many aspects of skin and haircare product development. He is a biologist, research scientist, educator, technical marketing champion, and a member of the scientific advisory board for the New York Society of Cosmetic Chemists. Michael has held positions across several multinational corporations, including Johnson & Johnson, Schering Plough, and Hoffman La Roche, encompassing roles in R&D, product development, technical marketing, and as a research fellow for technology vendors like Presperse and Vantage. He has also worked as VP of Operations and Technology for Eurofins CRL designing and executing human clinical studies around personal care products. Michael continues to lecture and present at conferences and has a list of patents and publications. This podcast is brought to you in partnership with VRM Media and Nutraland USA, Inc. For more information about our host and guest, please see the below information. vitaquest.com https://www.linkedin.com/in/michael-anthonavage-b4b9a96/ nutralandusa.com linkedin.com/in/gene-bruno-ms-mhs-rh-ahg-2ab0508/ www.vrmmedia.com @hnvirtual, #hnvirtual, #michaelanthonavage, #genebruno, #thevitaminprofessor Find our podcast on your favorite platform: podcasts.apple.com/us/podcast/the-vitamin-professor-podcast/id1746137375 youtube.com/channel/UCxeQ-IuqCRmq0YLc7jQNMKA music.amazon.com/podcasts/a8a96593-b93c-48cf-9fe9-2891c4035dad/the-vitamin-professor-podcast iheart.com/podcast/269-the-vitamin-professor-podc-175888136/

On this episode of The Vitamin Professor Podcast, Professor Gene Bruno talks to Michael Anthonavage of Vitaquest International. Michael Anthonavage currently serves as the VP of Innovation at Vitaquest International, dedicated to expanding the supplement market footprint and ensuring customers gain a competitive edge. Michael has expertise in bringing new technologies to the market, championing innovation and growth for all areas of health and nutrition as well as many aspects of skin and haircare product development. He is a biologist, research scientist, educator, technical marketing champion, and a member of the scientific advisory board for the New York Society of Cosmetic Chemists. Michael has held positions across several multinational corporations, including Johnson & Johnson, Schering Plough, and Hoffman La Roche, encompassing roles in R&D, product development, technical marketing, and as a research fellow for technology vendors like Presperse and Vantage. He has also worked as VP of Operations and Technology for Eurofins CRL designing and executing human clinical studies around personal care products. Michael continues to lecture and present at conferences and has a list of patents and publications. This podcast is brought to you in partnership with VRM Media and Nutraland USA, Inc. For more information about our host and guest, please see the below information. vitaquest.com https://www.linkedin.com/in/michael-anthonavage-b4b9a96/ nutralandusa.com linkedin.com/in/gene-bruno-ms-mhs-rh-ahg-2ab0508/ www.vrmmedia.com @hnvirtual, #hnvirtual, #michaelanthonavage, #genebruno, #thevitaminprofessor Find our podcast on your favorite platform: podcasts.apple.com/us/podcast/the-vitamin-professor-podcast/id1746137375 youtube.com/channel/UCxeQ-IuqCRmq0YLc7jQNMKA music.amazon.com/podcasts/a8a96593-b93c-48cf-9fe9-2891c4035dad/the-vitamin-professor-podcast iheart.com/podcast/269-the-vitamin-professor-podc-175888136/

About Jeff Savlov: Jeff Savlov is the Founder of Blum & Savlov, LLP, and consults with business families, legacy wealth families, and the advisors who serve them. He brings more than 30 years of unique experience in sales and marketing, business ownership, entrepreneurial endeavors, family dynamics/psychological training, and a common-sense style to his consulting work with families. By integrating his diverse business background, extensive academic work, and family dynamics/psychological training with his experience working in his family's commercial printing business, Jeff helps enterprising families balance family and business/wealth so both will thrive for generations. Jeff has consulted on relationship and team dynamics with Fortune 500 companies such as Bristol-Myers Squibb, Johnson & Johnson, and Schering Plough. He also devotes a portion of his time to performance enhancement with corporate executives and elite high school athletes. Check out the latest episode of our Conversational Selling podcast to learn more about Jeff.In this episode, Nancy and Jeff discuss the following:The role of the Sandler methodology in understanding client needs and building relationshipsJeff's background and journey into family consultingThe challenges faced by wealthy families and the specialized assistance they requireStrategies for acquiring clients: speaking engagements and referralsJeff's unique approach to using Metallica's story in his workshopsKey Takeaways: It's easy to idealize being wealthy, but there are many challenges.One of my areas is parenting in the context of family wealth and how to start when kids are young to raise them so that those values will remain there when they learn about money.DISC is excellent for people who don't have the training to help them think about the general categories that people fall into. "I got trained as a family therapist. After grad school, I did another seven years of training in a psychoanalytic institute for seven years. Like I said, I got fully certified and started a private practice doing talk therapy 30 years ago. And just by coincidence, some of my early therapy clients also had significant wealth or family businesses. I was working with them as a therapist, and I could see that there was a need that was different than therapy, but that lawyers, accountants, and wealth managers didn't have the training and background to go into the family dynamic side. So, I saw an opportunity to do something that was not therapy but between what a therapist and business consultants do. I started to work slowly and consult with families. Again, I'm not working on finance taxes or operations. I'm helping families develop strong family teams and work together two or three generations at a time. Now that people are living longer, you can easily have, you know, 80-year-olds, 50-year-olds, and 20-year-olds working together. I help them work together, develop leadership, communicate well, and make transitions from one generation to the next, helping the senior generation step back, give the next generation opportunity, and developing the next generation to step up and take over." – JEFF" In terms of meeting people and those early stages when I'm trying to decide if I want to work with them and they're trying to decide if they want to work with me, Sandler has been incredibly valuable. And what I just said is really at the heart of it. Sandler talks about a level playing field. So, it's not like, "Hey, I'm the poor guy with the poor schmuck with something to sell. I hope you'll buy it." It's more like I have something of value; I'm looking for people who need it, have pain around it that I can solve, and have respect for what I bring. And they're looking for someone to help them with their pain, and it's mutual. And Sandler, that part of the Sandler attitude is that it's a level playing field but a two-way street. I'm not just looking for anyone who'll hire me. And that's a big piece of it. I feel like the rapport part of the equation is something I've always been good at just naturally, and certainly years of being a therapist, and that's a big part of the Sandler piece." - JEFF"I find sales is fun. Even though I am primarily sort of a consultant and I'm doing, you know, professional consulting services, I must find— I'm a solo guy. I must find my, you know, my clients and serve them. And that is sales. And I think that sales— really, life is sales, not in a manipulative way, but life is about understanding people, seeing if there's a common need or desire, and then going for it. And so, I find it a lot of fun. Sometimes, I land a big client, and then I'm disappointed. I must do the work. Not that I don't enjoy the work, but I find sales— I love the hunt. And I find it enjoyable. I don't know, people think it's crazy that aren't into it." – JEFFConnect with Jeff Savlov:LinkedIn: https://www.linkedin.com/in/jeffsavlov/Blum & Savlov, LLP: https://blumandsavlov.com/about/Try Our Proven, 3-Step System, Guaranteeing Accountability and Transparency that Drives RESULTS by clicking on this link: https://oneofakindsales.com/call-center-in-a-box/  Connect with Nancy Calabrese: Twitter:https://twitter.com/oneofakindsalesFacebook:https://www.facebook.com/One-Of-A-Kind-Sales-304978633264832/Website:https://oneofakindsales.comPhone: 908-879-2911 LinkedIn: https://www.linkedin.com/in/ncalabrese/Email: leads@oneofakindsales.com 

On Jan 30, 2024 we discussed a few things including the latest  state of AI in #healthcare and #pharma. Panelists include:Kash Patel is the Executive Vice President and Chief Digital Information Officer, Hackensack Meridian Health, New Jersey's largest and most comprehensive health network. Mr. Patel has more than 25 years of experience in technology leadership, ranging from start-ups to multinational corporations and is a seasoned leader in health care with a strong focus on innovation and building great teams. Before HMH, Kash was the Vice President and Chief Digital Technology Officer at Penn Medicine.Donna Conroy has 25 years' pharmaceutical industry experience as both a Fortune 500 pharma executive and entrepreneur. Her career has focused on bringing science to patients. First as a microbiologist, then at Schering-Plough, where she led sales and marketing teams and built a $1.2B line of business.Named one of NJ's Top 25 Leading Women Entrepreneurs, Donna led SciMar's acceptance into the Merck Digital Science Studio 2023 cohort and 2021 acceptance into Microsoft for Startups. She is a graduate of Microsoft's prestigious Women in Cloud Accelerator and was named 2021 Top 10 Most Successful Women in Cloud Entrepreneurs.Rohit Vashisht is the co-founder and CEO of WhizAI, a generative AI-powered analytics platform purpose-built for Life Sciences and Healthcare. WhizAI was recently recognized by Inc Media as one of the 500 fastest-growing private companies in the US. He has over 20 years of experience in enterprise software sales, product management, development, and strategy. As a tech entrepreneur, Rohit has built successful businesses and was CEO and co-founder of Sverve – an influencer marketplace that was acquired by Bloglovin and rebranded as Activate.#lifesciences  #drugdiscovery #innovation #podcast #AFewThingsPodcast

Synopsis: In this episode of Biotech2050, Scott Megaffin, CEO of Adiso Therapeutics, shares valuable insights on the challenges and opportunities in the biotech industry. His deep involvement in the pharmaceutical and biopharmaceutical sector has shaped his strategic approach to leadership and business management. Scott emphasizes the importance of a CEO's versatility and willingness to undertake any task, no matter how small, and also highlights the burden of proving the value of differentiation in a small company. The conversation delves into the significance of collaboration with research institutions and strategic partners, underlining the importance of differentiation and collaboration in competitive markets. Scott's reflections on his career journey and the development of Adiso's asset Adso 51 provide valuable lessons for professionals and entrepreneurs in the field, making this episode a must-listen for biotech entrepreneurs and professionals seeking to enhance their ability to differentiate and collaborate in competitive markets. Biography: Scott joined Adiso Therapeutics as Chief Executive Officer in January 2022, bringing more than 35 years of successful industry leadership, having held multiple senior executive, CEO and board director roles during his career at both Fortune 500 pharmaceutical and emerging biotechnology companies. Among Mr. Megaffin's many career leadership roles, he previously served as the CEO of Adastra Pharmaceuticals Inc., a pioneer in the pursuit of better treatment options for high unmet need cancers, where he led the company from early informative to clinical-stage advancement of first-in-class clinical programs, and ultimately to its acquisition by Cothera Bioscience. Earlier, he served as a President of Churchill Pharmaceuticals, Inc., leading the organizational growth and development of a fully differentiated oral oncology asset for metastatic castrate resistant prostate cancer through FDA approval and ultimately a transaction to Sun Pharma. Mr. Megaffin has held numerous global strategic and operational positions of increasing responsibility within Onconova, Schering-Plough, Yamanouchi, Pharmacia, and Bristol-Myers Squibb. During his career Scott has led six global drug development programs resulting in regulatory approvals. He possesses far reaching knowledge in a broad number of therapeutic categories including oncology, anti-infectives, inflammation, pain, critical care, and virology. Mr. Megaffin currently serves as a board member of Adastra and on the Board of Directors for BioNJ, the biotechnology and life science organization of New Jersey. Mr. Megaffin holds a B.S. in Biology from Pittsburg State University.

Executivo do setor da saúde há +20 anos, atuou em empresas como: Novartis, Schering-Plough, MSD, Biolab e Medtronic, responsável pelo "Commercial Training" na América Latina. Idealizador do "Braintalks, neurociência ao alcance de todos", professor de Neurociência do Einstein Ensino e da Faculdade de Ciências Médicas da Santa Casa de SP. Palestrante de assuntos ligados a gente”, “performance”, “neurociência” e “futuro. Palestrou no TED❌ com o tema: Conhecimento que transforma. Em 2023 lançou seu livro: Neuromanagement, cérebro e a gestão do futuro de pessoas e organizações. --- Send in a voice message: https://podcasters.spotify.com/pod/show/coachcast2020/message

Craig Thompson is the Chief Executive Officer of Cerevance ( https://www.cerevance.com/about ), a private, clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system (CNS) diseases using the company's proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) technology, a machine learning platform that helps measure precise levels at which thousands of genes are expressed in any cell type in any region of the brain, and then map those genes to specific diseased and healthy brain states. Most recently, Mr. Thompson was President and Chief Executive Officer of Neurana Pharmaceuticals. Prior to Neurana, Mr. Thompson was President and Chief Executive Officer of Anthera Pharmaceuticals. Mr. Thompson's previous biotech experience includes Chief Operating Officer for Tetraphase Pharmaceuticals and Chief Commercial Officer for Trius Therapeutics where he was involved in the $707M up front acquisition of Trius by Cubist Pharmaceuticals, as well as a partnership with Bayer Pharma AG. Prior to Trius, Mr. Thompson served in various global and U.S. roles at Pfizer Inc., including Therapeutic Group Leader of Allergy, Respiratory, Pulmonary Vascular Disease and Inflammation; and ultimately served as Vice President of Marketing for Pfizer's Specialty Care Business Unit. Previous to Pfizer, Mr. Thompson served in positions of increasing responsibility at Merck & Co., Inc including leading the partnership with Schering Plough. Mr. Thompson holds a Bachelor's degree in Commerce from McMaster University and an M.B.A. from the University of Notre Dame. Support the show

Dr. Robert Seik is known for his cutting edge and forward-thinking solutions to traditional medical treatment challenges. He owns and operates the Partell Independent Compounding Pharmacy in Las Vegas, NV, which is the preferred independent pharmacy partner of The Wellness Company. Dr. Seik has extensive experience in the pharmaceutical and biotech industries working with national networks of research physicians for companies including Schering-Plough, InterMune, and Valeant Pharmaceuticals. During his career Dr. Seik was involved in the research and marketing of novel agents for the treatment of various infectious diseases, endocrine, and immune disorders. Huge thank you to The Wellness Company for connecting us to have this meaningful conversation. Learn more about The Wellness Company and enjoy a discount on their products and services by going to https://www.twc.health/freemind.

Dr. Robert Seik is known for his cutting edge and forward-thinking solutions to traditional medical treatment challenges. He owns and operates the Partell Independent Compounding Pharmacy in Las Vegas, NV, which is the preferred independent pharmacy partner of The Wellness Company. Dr. Seik has extensive experience in the pharmaceutical and biotech industries working with national networks of research physicians for companies including Schering-Plough, InterMune, and Valeant Pharmaceuticals. During his career Dr. Seik was involved in the research and marketing of novel agents for the treatment of various infectious diseases, endocrine, and immune disorders. Huge thank you to The Wellness Company for connecting us to have this meaningful conversation. Learn more about The Wellness Company and enjoy a discount on their products and services by going to https://www.twc.health/freemind.

Neste episódio do Podcast CRUZAMENTO, André Correia e Daniel Guedelha conversam com Sofia Ferreira, uma líder inspiradora no campo da saúde feminina, sobre um tema de extrema importância e central na luta contra a desigualdade: investir na saúde da mulher. Falámos também sobre o papel revolucionário dos DAOs (Organizações Autónomas Descentralizadas) na área da saúde. Vamos fazer da saúde feminina uma prioridade e promover a igualdade de acesso aos cuidados de saúde. Juntos, podemos fazer a diferença! Sofia Ferreira is the new Managing Director of Organon Portugal. She is a pharmacist by training with a degree marketing and an MBA. Sofia started her career in Schering-Plough where she worked for 10 years in roles with increasing responsibilities. Upon the acquisition of Schering-Plough, she has moved to MSD, where she held multiple roles of increasing responsibility, including people manager roles, in different therapeutic areas, from WH, to Established Brands, Vaccines and Hospital Specialties. After 10 years, she has decided to change and joined Organon in Portugal as Marketing and Sales Director, managing a broad portfolio of products. She is an invited teacher in AESE, one of the most important business schools in Portugal, giving lectures on pharmaceutical industry marketing and communication. She is also an active member of Women Leadership groups and is an invited guest to podcasts and conferences on the topic. Outside of work, Sofia is happily married to João and they have 2 children, Rodrigo with 16 years old and Vicente with 10 years old. Other relevant references | Outras referências relevantes: Organon, here for her health Organon: Jobs Athena DAO Podcast Cruzamento #05: Inês Santos Silva e o Empreendedorismo no Feminino Podcast Cruzamento #59: "Nelson Jordan: Does DAO (Decentralised Autonomous Organisation) ring a bell? Contacts | Contactos: CruzamentoPodcast.com cruzamentopodcast@gmail.com LinkedIN: Cruzamento Twitter: @cruzamentofm Facebook: @podcastcruzamento Instagram: @cruzamentopodcast YouTube: Podcast Cruzamento

Synopsis: Craig Thompson is the CEO of Cerevance, a clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system diseases. He discusses the arc of his career, beginning at big pharma at Merck and Pfizer before transitioning to biotech, and his learnings along the way. As CEO, he shares what he's learned about developing a relationship with his board and the value they bring to his company. He also talks about the current CNS landscape, where Cerevance is from a development perspective, and the unique way the company approaches AI. Biography: Craig Thompson is the Chief Executive Officer of Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel therapeutics for central nervous system (CNS) diseases using the company's proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform. Most recently, Mr. Thompson was President and Chief Executive Officer of Neurana Pharmaceuticals. Prior to Neurana, Mr. Thompson was President and Chief Executive Officer of Anthera Pharmaceuticals. His previous biotech experience includes Chief Operating Officer for Tetraphase Pharmaceuticals and Chief Commercial Officer for Trius Therapeutics where he was involved in the $707M up front acquisition of Trius by Cubist Pharmaceuticals, as well as a partnership with Bayer Pharma AG. Prior to Trius, Mr. Thompson served in various global and U.S. roles at Pfizer Inc., including Therapeutic Group Leader of Allergy, Respiratory, Pulmonary Vascular Disease and Inflammation; and ultimately served as Vice President of Marketing for Pfizer's Specialty Care Business Unit. Previous to Pfizer, Mr. Thompson served in positions of increasing responsibility at Merck & Co., Inc including leading the partnership with Schering Plough. Mr. Thompson holds a Bachelor's degree in Commerce from McMaster University and an M.B.A. from the University of Notre Dame.

Hank A Laskey, PhD holds a Bachelors degree in Chemistry and a Masters degree in Management, both from Clemson University and a Doctorate in Marketing from the University of Georgia. He was the Director of the MBA program in Pharmaceutical and Chemical Studies at Fairleigh Dickenson University prior to leaving academia to pursue business interests in 2004. During the next ten years, he was involved in the start up of four companies in the field of pharmaceuticals and biotechnology. He has been an invited speaker for major companies within the industry and also at numerous industry conferences. Dr. Laskey has taught specialized courses for Bayer, Johnson & Johnson and Schering-Plough. He brings a broad-based perspective on the pharmaceutical industry from both academia and the private sector.https://www.amazon.com/Global-Pharmaceutical-Industry-Government-Regulation/dp/1543463509

Dr. Derek Lowe is a medicinal chemist, author, and blogger. He is currently Director in Chemical Biology and Therapeutics at the Novartis Institutes for Biomedical Research (NIBR). Dr. Lowe's work in drug discovery has spanned multiple decades with tenures at Schering-Plough, Bayer, and Vertex Pharmaceuticals. In addition to his industry work, Dr. Lowe authors a popular blog covering topics in drug discovery; check it out here: In the Pipeline.

Synopsis: Bill Hinshaw is the President and CEO of Axcella Therapeutics, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions. Bill entered biotech a little over four years ago following a long life sciences career in pharma, working for companies such as Novartis and Schering Plough. He joins host Rahul Chaturverdi for a discussion about where Axcella is from a development perspective and the therapeutic areas they're pursuing, the company's work to treat long Covid, the challenges of developing drugs to treat nonalcoholic steatohepatitis (NASH), and Axcella's “combination by design” multi-targeted approach to tackle complex diseases. Read More on Axcella Announces Positive Interim Data from Phase 2b EMMPACT Study of AXA1125 in Nonalcoholic Steatohepatitis (NASH) https://bit.ly/3U0iEa6 Biography: Mr. Hinshaw joined Axcella as CEO in May 2018. He is the former Executive Vice President of U.S. Oncology at Novartis Pharmaceuticals Corporation, having served 15 years with the organization. Mr. Hinshaw led all aspects of this >$6B organization, heading up more than a dozen product launches, including Tasigna®, Gleevec®, and Kymriah®; the integration of the GSK oncology portfolio; innovative medical, commercial, and market access models; and a patient-centric focus on education and support programs. He also played a key role on the Global Oncology Executive Committee, including leading key strategic programs to maximize the portfolio and pipeline development. Mr. Hinshaw was formerly the Head of the Northern and Central Europe Region for Novartis Oncology where he was responsible for leading all functions across 33 countries. Prior to that role, Mr. Hinshaw was the head of Group Emerging Markets, which included all divisions of Novartis in 50 countries worldwide. Prior to his role as EVP, Mr. Hinshaw held a number of lead roles for Novartis, including Head of the Hematology Business Franchise, which achieved >20% overall growth each year under Mr. Hinshaw's leadership. He also was the Global Head of Infectious Disease and Transplantation and Immunology (IDTI) based out of Basel, Switzerland, with responsibility for all functions of the organization, including commercial, development, BD&L, and strategy for the Business Unit. Other Novartis positions held by Mr. Hinshaw included Global Head of Infectious Disease Marketing and IDTI Development and Business Development & Licensing; Business Franchise Head, Infectious Disease; and Head of Infectious Disease Marketing. Mr. Hinshaw started his career at Schering Plough, where over the course of 12 years, he held a series of roles of increasing responsibility in the sales and marketing functions in both primary care and specialty business units, including market research, new products and in-line brand management, and sales positions at the representative, district, regional, and national levels. He also led the U.S. Oncology Unit where he was responsible for sales, marketing and business development. Mr. Hinshaw holds a B.S. in Molecular Biology from the University of Wisconsin.

In two companies, Nick Brignola, has shown the power of FP&A steering big ticket medical acquisitions. Firstly,  almost a decade ago, Nick led FP&A at manufacturing medical company, Schering-Plough snapped up by Merck in a $41.1 billion deal. Then in June 2022, at Cloudmed, Nick's FP&A team oversaw the Atlanta-based healthcare revenue recovery provider being acquired by Revenue cycle management company R1 RCM ( $4.1 billion). In this straight-talking episode Nick reveals the secret inside story of FP&A's behind the scenes role in closing M&A deals. He also discusses: Getting to 1% Forecast Accuracy in Pharma and the lessons others can learn. The vital metrics anyone in pharma manufacturing need to know. What are the main differences betweeen Corporate FP&A or Business Unit (or operational) FP&A? FP&A Vs Sales The secret for FP&A teams to truly challenge your sales team (productively) His secrets to building the most effective and dynamic FP&A team which bring results Follow Nick Brignola on LinkedIn Follow Paul Barnhurst on LinkedIn Follow Datarails on LinkedIn FP&A Today is brought to you by Datarails. Datarails is the financial planning and analysis platform that automates data consolidation, reporting and planning, while enabling finance teams to continue using their own Excel spreadsheets and financial models. Get in touch at www.datarails.com Read the Blog and Full Program Transcript Watch the Full Episode on YouTube  To suggest a great guest for the show, or if you would like to be the FP&A Leader being interviewed contact jonathan.m@datarails.com

No matter what business you are in and what your goals are, becoming better at sales is essential to achieve what you are aiming for. I know it might not be your favorite topic, but I'm excited for you to hear from the expert I brought on to learn how to be better at selling virtually, which is the most common method of sales in today's world. Nitya Kirat has built, delivered, and coached sales and sales leadership development programs at companies including PIMCO, BlackRock, Allianz Global Investors, MetLife, Google, Causeway Capital, and Transamerica.   Nitya has worked in sales and consulting roles for the past 18 years. He was an award-winning salesperson at Schering-Plough and UBS prior to starting YOSD. Nitya's sales strategies have also been influenced by his global perspectives, having lived and worked in several parts of the world including Singapore, India, Tanzania, and Belgium. Highlights: 3:22 - Some people have the fortune of knowing exactly what they want to be at five years old. Others have the fortune of having to go through a journey to figure it out. 12:02 - There is no such thing as too much rapport. Let the relationship take its course. Intimacy in relationships is a part of trust.  19:49 - There's nature vs. nurture to sales. There are definitely people who are built for making calls and getting rejected and being excited about the next call. If you're the leader of a company, those are the types of people you want to vet in your interview process. Then there's nurture: things like goal setting, time management, and call blocking. 27:57 - Identify three questions to ask a potential customer that will help build rapport before a sale. Connect with Kristin https://www.instagram.com/meetkristinburke/ (Instagram) https://kristinburke.com/ (Website) Connect with Nitya  https://www.linkedin.com/in/nitya-kirat-84a1671/ (LinkedIn) https://www.yosdconsulting.com/ (Website) Links Mentioned https://www.linkedin.com/posts/nitya-kirat-84a1671_how-to-improve-your-sales-skills-even-if-activity-6884526114497183744-H8XK (How to Improve Your Sales Skills, Even If You're Not a Salesperson) https://www.yosdconsulting.com/ (Sales Improvement | YOSD CONSULTING | United States)

Know Stroke Podcast Ep 34 -Spotlight on Afib Awareness September is Afib Awareness Month. Atrial fibrillation (Afib) is the most common irregular heartbeat and is characterized by heart palpitations, dizziness, and shortness of breath. Afib is sometimes silent and may not exhibit symptoms at all yet it increases stroke risk and can lead to heart failure, kidney problems and dementia. It can also increase your risk of death so early detection and treatment is critical to reduce risk. About our Guest: On today's show we were joined by James Amihood, CEO of Cardiokol Cardiokol is a privately-owned digital telehealth company that develops voice-based markers and methods for monitoring and screening heart rhythm disorders in large at-risk populations. James has 25 years of management experience including CEO of PRM Inc., GM of Syqe Medical and senior positions at multinational pharmaceutical and healthcare companies (Teva, Schering Plough, Perrigo), managing subsidiaries and heading BD and M&A. He holds BSc in Chemistry, BSc IE, MBA Learn more here:  https://www.cardiokol.com/ Today's Show Resources: Afib Awareness Resource https://www.stopafib.org Apple Watch Study https://www.fiercehealthcare.com/digital-health/nih-funded-study-test-if-apple-watch-can-prevent-strokes-limit-blood-thinners Show Info: Music intro credit to Jake Dansereau, connect at JAKEEZo on Soundcloud @user-257386777.  Our intro welcome is the voice of Caroline Goggin, a stroke survivor and our first podcast guest! Please listen to her inspiring story on Episode 2 of the podcast. Thank you Caroline! Until next time, be sure to give the show a like and share, +follow and connect with us on social or contact us to be a guest on the Know Stroke Podcast https://www.know-stroke.org

Dr. Ying Huang currently serves as Chief Executive Officer of Legend Biotech. He sits on the Board of Directors of Legend, as well as Quanta Therapeutics. Dr. Huang brings over 9 years of experience in research and development at major multi-national pharmaceutical companies and 12 years of experience as a biotechnology analyst on Wall Street. Dr. Huang was a Managing Director and Head of Biotech Equity Research at Bank of America Merrill Lynch where he led a team of analysts covering more than 30 biotechnology companies that encompass a wide range of therapeutic areas. His knowledge and expertise have been recognized by the Institutional Investor survey as a top ranked biotechnology analyst on Wall Street. Dr. Huang previously worked at Wachovia, Credit Suisse, Gleacher and Barclays before joining Bank of America Merrill Lynch. Besides providing investment research to investors, Dr. Huang and his team conducted due diligence for numerous successful initial public offerings (IPOs) and follow-on offerings in the biotechnology sector. Prior to his Wall Street career, Dr. Huang was a Principal Scientist at Schering-Plough in the Department of Chemical Research focusing on small molecule drug discovery in the therapeutic areas of cardiovascular and central nervous system. He is the co-author of multiple patents and peer reviewed publications. Dr. Huang received his Doctor of Philosophy in Bio-organic Chemistry from Columbia University. He also studied in the Special Class for the Gifted Young at the University of Science and Technology of China and Columbia Business School.

In this episode of Money Tales, our guest is Jeff Savlov. Jeff started working at an early age in his family business, a growing commercial printing operation. His first role was to peel off strips of silver in the film that was otherwise garbage so they could sell the silver for cash. Jeff learned firsthand the challenges that come with working for your dad. As Jeff shared with us, his dad took out the business frustrations on Jeff because it was safe. Jeff, after all, was family. They ultimately hired a therapist to help address the challenging family dynamics. This experience inspired Jeff's ultimate career decision. Jeff is founder of Blum & Savlov, LLP - Family Business & Wealth Consulting and works with family businesses, high net-worth families, family offices and their advisors with a focus on balancing family dynamics with ownership and management of shared assets across generations. Jeff's specialty is working with families that want their wealth to serve current and future generations in healthy and productive ways and he loves coaching parents on raising children in a family business/wealth context to harness potential and avoid common, painful pitfalls. He speaks in the U.S. and internationally, has been quoted in the NY Times, Family Business Magazine, and authors a popular blog - “The Family Business Minute.” Jeff brings more than 25 years of unique experience in sales and marketing, business ownership, entrepreneurial endeavors and family dynamics training, along with a common sense style, to his consulting work with families. By integrating his diverse business background, extensive academic work and family dynamics/psychological training with his experience working in his family's commercial printing business, Jeff helps enterprising families to balance family dynamics and business so both will thrive for many generations. Having participated in his family's business, Jeff understands first-hand the challenges of balancing the interplay between family and business and the devastation that can befall an otherwise healthy business when this balance is not proactively managed. In the business Jeff's family owned, a consultant was brought in to work with the family, facilitated a successful reorganization of the business and helped rebuild family relationships. This is one of the primary experiences which motivated Jeff's career in family business/family wealth consulting. Jeff holds a Master of Social Work degree from Rutgers University with specializations in group dynamics and family systems theory and has a post-graduate certification from the Institute for Psychoanalysis and Psychotherapy of New Jersey (now the Center for Psychoanalysis and Psychotherapy of NJ) where he is a member of the faculty. He earned an Advanced Certificate in Family Business Advising and Fellow status from the Family Firm Institute (FFI), Boston, MA. In addition, he has consulted with Fortune 500 companies such as Bristol-Myers Squibb, Johnson & Johnson and Schering Plough. He also devotes a portion of his time to performance enhancement with corporate executives and elite high school athletes. Through membership in the Family Firm Institute, an international organization comprised of family business and family wealth advisors, consultants, educators and researchers, and the Purposeful Planning Institute, Jeff has access to the latest trends, developments, best practices and research in family business and family wealth consulting. Jeff is the founder of the Princeton Family Business Consultants Group - an interdisciplinary group of professionals serving enterprising families across the U.S. and convening to develop best practices. Jeff lives in New Jersey with his wife and two children. He coaches youth sports and makes time for his lifelong passion – ice hockey. Jeff approaches his life and work with creativity and a sense of humor. See all episodes >

In this episode of Money Tales, our guest is Jeff Savlov. Jeff started working at an early age in his family business, a growing commercial printing operation. His first role was to peel off strips of silver in the film that was otherwise garbage so they could sell the silver for cash. Jeff learned firsthand the challenges that come with working for your dad. As Jeff shared with us, his dad took out the business frustrations on Jeff because it was safe. Jeff, after all, was family. They ultimately hired a therapist to help address the challenging family dynamics. This experience inspired Jeff's ultimate career decision.Jeff is founder of Blum & Savlov, LLP - Family Business & Wealth Consulting and works with family businesses, high net-worth families, family offices and their advisors with a focus on balancing family dynamics with ownership and management of shared assets across generations. Jeff's specialty is working with families that want their wealth to serve current and future generations in healthy and productive ways and he loves coaching parents on raising children in a family business/wealth context to harness potential and avoid common, painful pitfalls. He speaks in the U.S. and internationally, has been quoted in the NY Times, Family Business Magazine, and authors a popular blog - “The Family Business Minute.”Jeff brings more than 25 years of unique experience in sales and marketing, business ownership, entrepreneurial endeavors and family dynamics training, along with a common sense style, to his consulting work with families. By integrating his diverse business background, extensive academic work and family dynamics/psychological training with his experience working in his family's commercial printing business, Jeff helps enterprising families to balance family dynamics and business so both will thrive for many generations.Having participated in his family's business, Jeff understands first-hand the challenges of balancing the interplay between family and business and the devastation that can befall an otherwise healthy business when this balance is not proactively managed. In the business Jeff's family owned, a consultant was brought in to work with the family, facilitated a successful reorganization of the business and helped rebuild family relationships. This is one of the primary experiences which motivated Jeff's career in family business/family wealth consulting.Jeff holds a Master of Social Work degree from Rutgers University with specializations in group dynamics and family systems theory and has a post-graduate certification from the Institute for Psychoanalysis and Psychotherapy of New Jersey (now the Center for Psychoanalysis and Psychotherapy of NJ) where he is a member of the faculty. He earned an Advanced Certificate in Family Business Advising and Fellow status from the Family Firm Institute (FFI), Boston, MA. In addition, he has consulted with Fortune 500 companies such as Bristol-Myers Squibb, Johnson & Johnson and Schering Plough. He also devotes a portion of his time to performance enhancement with corporate executives and elite high school athletes.Through membership in the Family Firm Institute, an international organization comprised of family business and family wealth advisors, consultants, educators and researchers, and the Purposeful Planning Institute, Jeff has access to the latest trends, developments, best practices and research in family business and family wealth consulting. Jeff is the founder of the Princeton Family Business Consultants Group - an interdisciplinary group of professionals serving enterprising families across the U.S. and convening to develop best practices.Jeff lives in New Jersey with his wife and two children. He coaches youth sports and makes time for his lifelong passion – ice hockey. Jeff approaches his life and work with creativity and a sense of humor.Learn more about Money Tale$ > Subscribe to the podcast

Biotech scientist, Mike Donio was fired for his refusal to comply with injection mandates. Join him and myself for a deep dive into why he's now speaking out against the industry, how trusting the science is exactly what we shouldn't do, and what the scientific method really is. He's going to show us the unknown mechanism for most approved drugs, and improper models and artifacts of preparation, insider knowledge about the reproducability crises, cancer, viruses, and fraudulent tests. Mike's aim is to encourage more scientists to speak out and for the people to become their own experts. Jump on the livestream Wednesday March 2, 1:00 PM CST or watch the recording below after that time. Read More About Him: Mike Donio holds a bachelor's degree in Biochemistry and Molecular Biology with a Minor in Chemistry from the University of Massachusetts and a master's degree in Biotechnology with a concentration in Biotechnology Enterprise from JohnsHopkins. He is an accomplished scientist with 20 years of experience, including 15 years in the biotech and pharmaceutical industry. This experience spans the spectrum of drug discovery ranging from target identification through pre-clinical and IND-enabling studies. His first job as a scientist was in the lab of a top infectious disease doctor doing HIV research. Following that, he went into the pharma industry working several years at Schering-Plough which was subsequently acquired by Merck. Next, he decided to mix things up and worked for a few years at Eurofins, a Contract Research Organization. Finally, he spent the last 6 years at a biotech company in the Immuno-Oncology space, where he was most recently a Senior Scientist, developing antibodies to treat cancer. Despite this extensive experience and accomplishments over the last 20 years, Mike was let go from his most recent role at the biotech company for not consenting to take the Covid vaccine due to his deeply held religious beliefs. Follow Mike here: Channel: https://t.me/scientistsforhealthfreedom Chat: https://t.me/S4HFchat Blog: https://stillinthestorm.substack.com --- Send in a voice message: https://anchor.fm/beth-martens/message

On this Alfacast Biotech scientist, Mike Donio tells us why he did not comply with the Cootie Mandate and that "the Science" is not to be trusted. Biotech scientist, Mike Donio, has quite a story to tell! With advanced degrees in Biochemistry & Molecular Biology from esteemed universities including a concentration in Biotechnology Enterprise from Johns Hopkins he'll share the inside scoop on the so-called Scientific Method. During Mike's two decades in the biotech and pharmaceutical industry he witnessed first-hand how trusting the science is exactly what we shouldn't do, and what the Scientific Method really is. He's going to show us the unknown mechanism for most approved drugs, and improper models and artifacts of preparation, insider knowledge about the reproducibility crises, cancer, viruses, and fraudulent tests. This experience spans the spectrum of drug discovery ranging from target identification through pre-clinical and IND-enabling studies. His first job as a scientist was in the lab of a top infectious disease doctor doing HIV research. Following that, he went into the pharma industry working several years at Schering-Plough which was subsequently acquired by Merck. Next, he decided to mix things up and worked for a few years at Eurofins, a Contract Research Organization. Finally, he spent the last 6 years at a biotech company in the Immuno-Oncology space, where he was most recently a Senior Scientist, developing antibodies to treat cancer.  Despite this extensive experience and accomplishments over the last 20 years, Mike was let go from his most recent role at the biotech company for not complying with the Cootie mandate due to his deeply held religious beliefs. Mike's aim is to encourage more scientists to speak out and for the people to become their own experts. We couldn't agree more, and Mike's courage to speak the truth during these times of universal deceit bespeaks the revolution in Consciousness now underway! Show Links: https://t.me/scientistsforhealthfreedom Join Our Telegram: https://t.me/aflavedic    

Episode 39: Mike Donio - Scientist Questions The Science Mike Donio holds a bachelor's degree in Biochemistry and Molecular Biology with a Minor in Chemistry from the University of Massachusetts and a master's degree in Biotechnology with a concentration in Biotechnology Enterprise from Johns Hopkins.  He is an accomplished scientist with 20 years of experience, including 15 years in the biotech and pharmaceutical industry.  This experience spans the spectrum of drug discovery ranging from target identification through pre-clinical and IND-enabling studies.  His first job as a scientist was in the lab of a top infectious disease doctor doing HIV research.  Following that, he went into the pharma industry working several years at Schering-Plough which was subsequently acquired by Merck.  Next, he decided to mix things up and worked for a few years at Eurofins, a Contract Research Organization.  Finally, he spent the last 6 years at a biotech company in the Immuno-Oncology space, where he was most recently a Senior Scientist, developing antibodies to treat cancer.  Despite this extensive experience and accomplishments over the last 20 years, Mike was let go from his most recent role at the biotech company for not consenting to take the Covid vaccine due to his deeply held religious beliefs. Mike joins me to talk about his journey of realising that something was amiss in the world of science. In this podcast we discuss the failings of the scientific method, scientism and scientific dogma, cancer research, drug research, HIV research and much much more. If you are a scientist and like Mike, you are also questioning things, head on over to his telegram channel "Scientists For Health Freedom" which has over 200 scientists from around the world speaking out about the "science" https://t.me/S4HFchat Disclaimer: This podcast is for general information purposes only. It does not constitute as health advice and does not take the place of consulting with your primary health care practitioner. The views and opinions expressed in this podcast are those of the guest speaker and do not necessarily reflect those of Humanley, the presenter or any other entities or third parties associated with Humanley or the presenter. The right to freedom of opinion is the right to hold opinions without interference, and cannot be subject to any exception or restriction. We encourage the audience to use their critical judgement and use due diligence when interpreting the information and topics discussed in this podcast.

OMAR L HARRIS (Charlotte, NC, born in Pittsburgh, PA) is the founder of Intent Consulting, TYMPO.io, and EquityPulse.io, a Former GM (GSK and Allergan), Gallup Certified Strengths Coach, Speaker, Award-Winning Bestselling Author of 5 books, including "Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion", June 25, 2021, “The Servant Leader's Manifesto”, 2020, and “Leader Board: The DNA of High-Performance Teams”, 2019). With 20+ years of global pharmaceutical executive experience building teams, Omar has worked on 4 continents (U.S., Middle East, Asia, and Latin America) for Pfizer, Merck, Schering-Plough, and more. His books and work have been featured by CNN HLN Weekend Express, Black News Channel, WPXI-TV NBC News Pittsburgh, CBS/ABC/FOX Lake Charles, The Beating Alpha Podcast, The Living Corporate Podcast, Real Leaders, Ladders, SHRM Blog, Thrive Global, CEO World Magazine, Human Capital Innovations (HCI) Podcast, VoiceAmerica, Roland Martin Unfiltered and many more. As fun facts, Omar speaks 5 languages, plays 7 instruments, and started his first company at the age of 7.  Website: omarlharris.com LinkedIn: omarlharris Facebook: omarlharris Instagram: omarl.harris Twitter: strengthsleader

In the absence of a robust digital strategy, and abundance in un-operational brick and mortar stores, Landmark Group India, one of the largest retail and hospitality companies in India had to pivot rather quickly for survival when the Covid pandemic hit. In this episode, Maria Villablanca uncovers how Landmark Group India embraced e-commerce, rethought it's inventory management strategies, and leveraged new technology and processes to serve its customers during the worst of the pandemic. Dr. Anil Chinnabhandar, the Senior Vice President of Omni-Retail Planning & Supply Chain at Landmark Group India helps us uncover this story, and shares with us the strategy that won him the Chief Supply Chain Officer of the Year award for the Retail Supply Chain sector. About the Speaker Dr. Anil Chinnabhandar is an engineering and retail planning & supply chain professional; passionate about transforming businesses into more value driven, innovative and profitable organizations. His specialisms include manufacturing, omni retail and supply chain management. He's worked with a number of global and Indian organizations like Landmark Group, Future Group, Woolworths, Coles Myer, DHL-Exel, Super Cheap Auto, Corporate Express, Harper Collins, LG, Samsung, Schering Plough, Eli Lilly, BAX Global and Tupperware. He is currently the Senior Vice President of Omni-Retail Planning & Supply Chain at Landmark Group India.

Gregory J. Divis serves as Avadel's Chief Executive Officer and a member of Avadel's Board of Directors. Greg was appointed CEO in June of 2019, after previously serving in several leadership roles within the company, including Chief Operating Officer, Executive Vice President, and Chief Commercial Officer. Greg brings over 30 years of experience in building and leading business and financial operations within the pharmaceutical industry. Prior to joining Avadel, Greg served as an Executive in Residence at Linden Capital Partners, a healthcare-focused private equity firm. He also served as President and Chief Executive Officer of Lumara Health, a specialty branded pharmaceutical company focused on women's health. Prior to Lumara, Greg held general management, sales, marketing, and business development roles at Schering-Plough, which was acquired by Merck & Co., Inc., and Sanofi-Aventis. Greg earned his bachelor's degree from the University of Iowa.

Omar L. Harris, former General Manager of GSK and Allergan, joins me in this conversation on race.  He has more than 20 years of experience as a global pharmaceutical executive. Omart is the founder and managing partner at Intent Consulting, a firm dedicated to improving employee experience and organizational performance. He is the author of "Leader Board: The DNA of High-Performance Teams", "The Servant Leader's Manifesto", and “Be a J.E.D.I. Leader, Not a Boss”.  Omar shares his journey to the top, the cost to him as a Black man in America, and how he came to speak out and no longer compromise his identity and his beliefs. Key topics: Omar's first experience with racism was when he was voted Prom King of his high school in Louisiana. The principal told him that he was “allowed” to be the Prom King to “snitch” on the other Black students. Harris refused, stood up to the principal, and kept his title What happened when Omar L Harris met Ku Klux Klansman David Duke while in high school How he was the only Black product manager, the only Black Director of Marketing and the only Black General Manager outside of Africa, and the only Black General Manager of a global company in the world The psychic toll of assimilation and having to whitewash himself without even realizing it Why he now feels responsible for opening the doors for other Black people How he refuses to compromise his values and will always speak out against racism and discrimination of any kind Why people who are not Black don't understand the full gravity of racism and the dangers of working while Black Why white people who call themselves allies must be willing to speak out and take a stand with friends, family, and colleagues even if parts of their lives unravel as a result How white allies can be more prepared to take action if they practice and prepare for different situations His books on leadership and how they are different than white leadership books. Why it's essential that every CEO needs to take action against racism, or they are not real leaders Check out his playlist, the TV shows he recommends, and the books he reads   Bio OMAR L HARRIS (Charlotte, NC, born in Pittsburgh, PA) is the founder of Intent Consulting and TYMPO.io (the world's first and best SaaS application for employee inclusion), a Former GM (GSK and Allergan), Business and Servant Leadership Thought-Leader, Speaker, Award-Winning Bestselling Author of 5 books, including "Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion", June 25 2021, “The Servant Leader's Manifesto”, 2020, and “Leader Board: The DNA of High Performance Teams”, 2019). With 20+ years of global pharmaceutical executive experience building teams, Omar has worked on 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. As a Gallup Certified Strengths Coach, Motivational Speaker, Entrepreneur and Florida A&M University Alumni, Harris is passionate about leading teams, high-performance coaching, and inspiring the future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviors.  Omar is also the Co-Author of “From Authors to Entrepreneurs F.A.T.E.: The Personal Side of Indie Publishing” (2015) and Author of “One Blood” fiction book (2011, pen name, Qwantu Amaru – currently being developed into a television series). Harris was a featured speaker at the 2021 International Institute of Leadership Conference with his compelling topic: “The End of the Boss – 7 Rules for the Modern Leader”, a keynote speaker at the Leadership Harrisburg Area Graduation event, a featured speaker at the 2021 Rising Leaders Summit, a featured speaker at the BB21 Rise Conference, and a featured coach at the 11th annual WBECS Summit. His work has been featured by CNN HLN Weekend Express, WPXI-TV NBC Pittsburgh, Black News Channel, The Jewish Journal, The Beating Alpha Podcast, The Living Corporate Podcast, Real Leaders, SHRM Blog, Thrive Global, CEO World Magazine, Human Capital Innovations (HCI) Podcast, VoiceAmerica Business, Culture Stew and many more. As fun facts, Omar speaks 5 languages, plays 7 instruments, and started his first company at the age of 7. https://www.omarlharris.com/

There is no question that the workforce is changing and the thought process of those in charge need to change with it.  On today's episode of Like A Real Boss, Omar L. Harris shares his tips on what leaders need to do today to make an impact on their team. OMAR L. HARRIS (Charlotte, NC, born in Pittsburgh, PA) is the founder of Intent Consulting and TYMPO.io (the world's first and best SaaS application for employee inclusion), a Former GM (GSK and Allergan), Business and Servant Leadership Thought-Leader, Speaker, Award-Winning Bestselling Author of 5 books, including "Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion", June 25 2021, “The Servant Leader's Manifesto”, 2020, and “Leader Board: The DNA of High-Performance Teams”, 2019). With 20+ years of global pharmaceutical executive experience building teams, Omar has worked on 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. As a Gallup Certified Strengths Coach, Motivational Speaker, Entrepreneur and Florida A&M University Alumni, Harris is passionate about leading teams, high-performance coaching, and inspiring the future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviors.  

About Omar L HarrisOmar L Harris is the founder of Intent Consulting and TYMPO.io, prior to that he has 20+ years of global pharmaceutical senior leadership executive experience building teams in 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. He was the youngest senior marketing director in Schering-Plough history. He is also a Gallup certified strengths coach, speaker, award-winning bestselling author of 5 books, including: Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion The Servant Leaders Manifesto Leader Board: The DNA of High Performance Teams He is passionate about leading teams, high-performance coaching, and inspiring the future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviours. Connect via Website https://www.omarlharris.com/ https://www.intentconsultants.co/about Connect With Omar on Social Media LinkedIn Facebook Instagram Twitter Some topics we cover in this episode: Johari Window & Self Awareness Dealing with unexpected language roadblocks that defined his mindset How being people first can overcome cultural barriers for leaders The importance of modelling the behaviour you want to see How to deal with the resistance leaders will inevitably face when making change positive changes to the culture. Trust equation and why it is so important to your leadership credibility Balconies and Basements (Strengths & Weakness Are Two Sides Of The Same Coin) How a rejection led to an opportunity 10 years later The distinction between a boss and a leader and how that has lead to the great resignation J.E.D.I. Leadership (Justice, Equity, Diversity and Inclusion) Organisations dedicated to holding businesses accountable Why leaders need to change the way they lead Powerful leadership lessons from his mum Connect with me Website: https://mindsetshift.co.uk/ Instagram: https://www.instagram.com/sopeagbelusi/ LinkedIn: https://www.linkedin.com/in/sopeagbelusi/ Twitter: https://twitter.com/Sope_Agbelusi Email: hello@mindsetshift.co.uk -------------------------------------------------------------------------------------- SPREAD THE WORD. LEAVE A RATING, REVIEW, AND FEEDBACKYou can do this on Apple podcast or on Stitcher Your ratings and reviews help us place the podcast in front of new leaders and listeners. I appreciate you and your support! --------------------------------------------------------------------------------------- Have a question, comment or a topic you want to be discussed? Send me a voice message: https://mindsetshift.co.uk/#ask-me-anything

About Omar L HarrisOmar L Harris is the founder of Intent Consulting and TYMPO.io, prior to that he has 20+ years of global pharmaceutical senior leadership executive experience building teams in 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. He was the youngest senior marketing director in Schering-Plough history. He is also a Gallup certified strengths coach, speaker, award-winning bestselling author of 5 books, including:  Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion The Servant Leader's Manifesto” Leader Board: The DNA of High Performance Teams” He is passionate about leading teams, high-performance coaching, and inspiring the future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviours.  Connect via Website https://www.omarlharris.com/ https://www.intentconsultants.co/about Connect With Omar on Social Media  LinkedIn Facebook Instagram Twitter Some topics we cover in this episode: Johari Window & Self Awareness Dealing with unexpected language roadblocks that defined his mindset How being people first can overcome cultural barriers for leaders The importance of modelling the behaviour you want to see How to deal with the resistance leaders will inevitably face when making change positive changes to the culture. Trust equation and why it is so important to your leadership credibility Balconies and Basements (Strengths & Weakness Are Two Sides Of The Same Coin) How a rejection led to an opportunity 10 years later The distinction between a boss and a leader and how that has lead to the great resignation J.E.D.I. Leadership (Justice, Equity, Diversity and Inclusion) Organisations dedicated to holding businesses accountable Why leaders need to change the way they lead Powerful leadership lessons from his mum Connect with me Website: https://mindsetshift.co.uk/ Instagram:  https://www.instagram.com/sopeagbelusi/ LinkedIn:  https://www.linkedin.com/in/sopeagbelusi/ Twitter: https://twitter.com/Sope_Agbelusi Email: hello@mindsetshift.co.uk  -------------------------------------------------------------------------------------- SPREAD THE WORD. LEAVE A RATING, REVIEW, AND FEEDBACKYou can do this on Apple podcast or on Stitcher Your ratings and reviews help us place the podcast in front of new leaders and listeners. I appreciate you and your support! --------------------------------------------------------------------------------------- Have a question, comment or a topic you want to be discussed? Send me a voice message: https://mindsetshift.co.uk/#ask-me-anything

About Omar L HarrisOmar L Harris is the founder of Intent Consulting and TYMPO.io, prior to that he has 20+ years of global pharmaceutical senior leadership executive experience building teams in 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. He was the youngest senior marketing director in Schering-Plough history.He is also a Gallup certified strengths coach, speaker, award-winning bestselling author of 5 books, including: Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and InclusionThe Servant Leader's Manifesto”Leader Board: The DNA of High Performance Teams”He is passionate about leading teams, high-performance coaching, and inspiring the future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviours. Connect via Websitehttps://www.omarlharris.com/https://www.intentconsultants.co/aboutConnect With Omar on Social Media LinkedInFacebookInstagramTwitterSome topics we cover in this episode:Johari Window & Self AwarenessDealing with unexpected language roadblocks that defined his mindsetHow being people first can overcome cultural barriers for leadersThe importance of modelling the behaviour you want to seeHow to deal with the resistance leaders will inevitably face when making change positive changes to the culture.Trust equation and why it is so important to your leadership credibilityBalconies and Basements (Strengths & Weakness Are Two Sides Of The Same Coin)How a rejection led to an opportunity 10 years laterThe distinction between a boss and a leader and how that has lead to the great resignationJ.E.D.I. Leadership (Justice, Equity, Diversity and Inclusion)Organisations dedicated to holding businesses accountableWhy leaders need to change the way they leadPowerful leadership lessons from his mumConnect with meWebsite: https://mindsetshift.co.uk/Instagram:  https://www.instagram.com/sopeagbelusi/LinkedIn:  https://www.linkedin.com/in/sopeagbelusi/Twitter: https://twitter.com/Sope_AgbelusiEmail: hello@mindsetshift.co.uk --------------------------------------------------------------------------------------SPREAD THE WORD. LEAVE A RATING, REVIEW, AND FEEDBACKYou can do this on Apple podcast or on StitcherYour ratings and reviews help us place the podcast in front of new leaders and listeners.I appreciate you and your support!---------------------------------------------------------------------------------------Have a question, comment or a topic you want to be discussed?Send me a voice message: https://mindsetshift.co.uk/#ask-me-anything

Eduardo Fachini– Diretor de Supply Chain na MSD - Graduado em Comercio internacional pela Universidade Municipal de São Caetano do Sul e MBA Administração pela FIA (Fundação Instituto de Administração). Possui +20 anos de experiência nas áreas de Supply Chain, importação e exportação, Operações e logística, tendo atuado em grandes multinacionais como Johnsons Controls, DHL, Net e Bayer. Atualmente é o responsável pela área de Supply Chain na MSD, tendo como responsabilidade toda Cadeia de Suprimentos.Se você estiver ouvindo esse episódio pelo Spotify não esqueça de clicar no botão “seguir”, se você estiver ouvindo pelo Apple Podcasts deixe 5 estrelas e comentário que eu leio todos. Me adiciona também no

Episode #74: Omar L. Harris is a pioneer in the pharmaceutical world and is blazing the trail for diversity, equity, and inclusion in workplaces around the world.  He has been blessed to work and live in 4 continents in his professional career and that has given him a perspective that you cannot buy.  Omar lends his insights on how to truly "lean into servant leadership", why diversity is so important in the workforce, and how we can open more doors to more qualified candidates.  He is on a mission to eradicate toxic leadership and replace it with J.E.D.I. leaders globally.  Tune in and learn how the W.H.O.M. process can help grow your team and your leadership skills!Bio:OMAR L. HARRIS (Charlotte, NC, born in Pittsburgh, PA) is the founder of Intent Consulting and TYMPO.io (the world's first and best SaaS application for employee inclusion), a Former GM (GSK and Allergan), Business and Servant Leadership Thought-Leader, Speaker, Award-Winning Bestselling Author of 5 books, including "Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion", Summer 2021, “The Servant Leader's Manifesto”, 2020, and “Leader Board: The DNA of High Performance Teams”, 2019). With 20+ years of global pharmaceutical executive experience building teams, Omar has worked on 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. As a Gallup Certified Strengths Coach, Motivational Speaker, Entrepreneur and Florida A&M University Alumni, Harris is passionate about leading teams, high-performance coaching, and inspiring future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviors. Omar is also the Co-Author of “From Authors to Entrepreneurs F.A.T.E.: The Personal Side of Indie Publishing” (2015) and Author of “One Blood” fiction book (2011, pen name, Qwantu Amaru – currently being developed into a television series). Harris was a featured speaker at the 2021 International Institute of Leadership Conference with his compelling topic: “The End of the Boss – 7 Rules for the Modern Leader” (March 2021). His book and work have been featured by CNN HLN Weekend Express, WPXI-TV NBC Pittsburgh, Black News Channel, The Beating Alpha Podcast, The Living Corporate Podcast, Real Leaders, SHRM Blog, Thrive Global, CEO World Magazine, Human Capital Innovations (HCI) Podcast, VoiceAmerica and many more. As fun facts, Omar speaks 5 languages, plays 7 instruments, and started his first company at the age of 7.Contact Omar:Website: https://www.omarlharris.com/Website: https://www.intentconsultants.co/aboutLinkedIn: https://www.linkedin.com/in/omarlharris/Facebook: https://www.facebook.com/authorleadercoachInstagram: https://www.instagram.com/omarl.harris/Twitter: https://twitter.com/strengthsleaderBuy his book “Be a J.E.D.I. Leader, Not a Boss”https://www.amazon.com/D-I-Leader-Not-Boss-Leadership-ebook/dp/B0956JS4H8/ref=sr_1_3?dchild=1&keywords=Omar+l+harris&qid=1623385686&sr=8-3

In this episode, we will hear an exclusive conversation from the recent CSV Virtual Event, "Digital Transformation Initiative" This discussion was moderated by Daniel Matlis and features Sam Cheemokati, Paul Hurlocker, and Ron Schardong.  The discussion will be focused on exploring organization-wide digital transformation initiatives. The panel will share their firsthand experiences of point solutions to platforms transitions. And, the best practices when shifting to cloud computing and the cloud-first approach. About the panel: Daniel Matlis Daniel R. Matlis is the Founder and President of Axendia – a trusted advisor to Life-Science and Healthcare executives on business, technology, and regulatory issues. Dan's career in the industry spans over 20-years and has included projects in research & development, manufacturing, regulatory compliance, business development and information technology. Prior to founding Axendia, Dan was General Manager & VP at Stelex (now a GE company) – a leading consultancy to life-science companies. He started his professional career at Ethicon, Inc., a Johnson & Johnson Company.   Sam Cheemakoti Sam is the GMP Head at Beiersdorf for the Coppertone Division overseeing GMP compliance of its computer and automated systems. Sam has held positions of increasing responsibility at various Pharmaceutical companies such as Bayer, Merck, and Schering Plough in the areas of Computer Systems Validation, IT Compliance, and Quality Assurance. As a Quality leader with 20+ years in the industry with a demonstrated ability to produce and deploy Part 11 and Data Integrity remediation programs, validation programs, quality systems, strategic initiatives for Quality and Compliance especially under conditions of the consent decree, acquisitions, and divestitures has lent him unique perspectives as a change ambassador and thought leader. Sam earned his MS in Industrial Engineering from Louisiana Tech University and his Project Management credentials from Villanova University. He more recently completed a course on Digital Transformation: Leading People, Data and Technology from the University of Berkeley under their Executive Education Program in order to gain synergies between the two journeys of Digital Transformation and Computer Software Assurance for Quality.    Paul Hurlocker Paul is the CTO at Spring Oaks Capital, a technology-driven financial services company whose mission is to reinvent the debt recovery industry by providing a customer-centered user experience and streamlined operations powered by data and machine learning. Paul previously served as the Senior Director and Vice President of the Center for Machine Learning for Capital One. Paul founded Notch, Co and served as the CEO before selling the company to Capital One. Ron Schardong Ron is privileged to lead Johnson & Johnson's Technology Quality group responsible for computerized systems validation of business applications in the Medical Devices, Consumer, and Pharmaceutical segments worldwide. The applications include ERP, Warehouse Management, Manufacturing, Laboratory, Quality Systems, Clinical, R&D, Enterprise Tools, Services, and Infrastructure. He has over 25 years of experience in quality engineering, supplier quality, quality auditing, quality management, regulatory compliance, and regulatory affairs. Ron is one of the original members of FICSA Group (FDA + Industry Computer Assurance Group).   Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com. 

Returning guest Omar L. Harris, Former GM (GSK and Allergan), Award-Winning Author (“The Servant Leader's Manifesto”), Thought-Leader & Intent Consulting Founder has a new book out go grab it now!!!  “Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity and Inclusion”  https://amzn.to/35E3YXv ABOUT: OMAR L HARRIS (Charlotte, NC, born in Pittsburgh, PA) is the founder of Intent Consulting and TYMPO.io (the world's first and best SaaS application for employee inclusion), a Former GM (GSK and Allergan), Business and Servant Leadership Thought-Leader, Speaker, Award-Winning Bestselling Author of 5 books, including "Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion", Summer 2021, “The Servant Leader's Manifesto”, 2020, and “Leader Board: The DNA of High Performance Teams”, 2019). With 20+ years of global pharmaceutical executive experience building teams, Omar has worked on 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. As a Gallup Certified Strengths Coach, Motivational Speaker, Entrepreneur and Florida A&M University Alumni, Harris is passionate about leading teams, high-performance coaching, and inspiring future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviors.  Omar is also the Co-Author of “From Authors to Entrepreneurs F.A.T.E.: The Personal Side of Indie Publishing” (2015) and Author of “One Blood” fiction book (2011, pen name, Qwantu Amaru – currently being developed into a television series). Harris was a featured speaker at the 2021 International Institute of Leadership Conference with his compelling topic: “The End of the Boss – 7 Rules for the Modern Leader” (March 2021). His book and work have been featured by CNN HLN Weekend Express, WPXI-TV NBC Pittsburgh, Black News Channel, The Beating Alpha Podcast, The Living Corporate Podcast, Real Leaders, SHRM Blog, Thrive Global, CEO World Magazine, Human Capital Innovations (HCI) Podcast, VoiceAmerica and many more. As fun facts, Omar speaks 5 languages, plays 7 instruments, and started his first company at the age of 7. https://www.omarlharris.com/ Intent Consulting Founder https://www.intentconsultants.co/about LinkedIn https://www.linkedin.com/in/omarlharris/

In this HCI Podcast episode, Dr. Jonathan H. Westover (https://www.linkedin.com/in/jonathanhwestover/) talks with Omar Harris about the intersection of social justice, equity, diversity and leadership. See the video here: https://youtu.be/DKPlHADYxys. Omar L. Harris (https://www.linkedin.com/in/omarlharris/) is the founder of Intent Consulting and TYMPO.io (the world's first and best SaaS application for employee inclusion), a Former GM (GSK and Allergan), Business and Servant Leadership Thought-Leader, Speaker, Award-Winning Bestselling Author of 5 books, including "Be a J.E.D.I. Leader, Not a Boss: Leadership in the Era of Corporate Social Justice, Equity, Diversity, and Inclusion", Summer 2021, “The Servant Leader's Manifesto”, 2020, and “Leader Board: The DNA of High Performance Teams”, 2019). With 20+ years of global pharmaceutical executive experience building teams, Omar has worked on 4 continents (U.S., Middle East, Asia and Latin America) for Pfizer, Merck, Schering-Plough and more. As a Gallup Certified Strengths Coach, Motivational Speaker, Entrepreneur and Florida A&M University Alumni, Harris is passionate about leading teams, high-performance coaching, and inspiring future leaders of today and tomorrow to adopt the servant leader mindset and stop toxic leadership behaviors. Check out Dr. Westover's new book, The Alchemy of Truly Remarkable Leadership, here: https://www.innovativehumancapital.com/leadershipalchemy. Check out the latest issue of the Human Capital Leadership magazine, here: https://www.innovativehumancapital.com/hci-magazine. Ranked in the Top 10 Performance Management Podcasts: https://blog.feedspot.com/performance_management_podcasts/ ; Ranked in the Top 10 Workplace Podcasts: https://blog.feedspot.com/workplace_podcasts/ ; Ranked in the Top 15 HR Podcasts: https://blog.feedspot.com/hr_podcasts/ ; Ranked in the Top 15 Talent Management Podcasts: https://blog.feedspot.com/talent_management_podcasts/ ; Ranked in the Top 15 Personal Development and Self-Improvement Podcasts: https://blog.feedspot.com/personal_development_podcasts/ ; Ranked in the Top 30 Leadership Podcasts: https://blog.feedspot.com/leadership_podcasts/

Nitya Kirat is the Founder and CEO of YOSD Consulting, a firm that focuses on helping sales teams improve results by identifying and impacting key behaviors and building customized training and coaching programs. He has built, delivered, and coached sales and sales leadership development programs at companies including PIMCO, BlackRock, Allianz Global Investors, MetLife, Google, Causeway Capital, and Transamerica. He is also the author of WINNING VIRTUALLY: 10 Tiny Habits For Big Virtual Selling Success.  Nitya has worked in sales and consulting roles for the past 18 years. He was an award-winning salesperson at Schering-Plough and UBS prior to starting YOSD Consulting. His sales strategies have also been influenced by his global perspectives, having lived and worked in several parts of the world including Singapore, India, Tanzania, and Belgium. Nitya Kirat, the Founder and CEO of YOSD Consulting, joins John Corcoran in this episode of the Smart Business Revolution Podcast to talk about building rapport and selling virtually. Nitya discusses how to prepare for a virtual meeting, tips for creating online content, and the importance of post-meeting follow-ups.

This week, Stacey is joined by Dr. Ginette Collazo, CEO of Human Error Solutions. Stacey and Ginette provide some insight into the identification and reduction of human error in GMP facilities. In pharmaceutical manufacturing, upwards of 80% of process deviations can be attributed to human error. While regulatory agencies make clear that all deviations, including those caused by human error, must be fully investigated – can we say that we are effectively doing that as an industry? About Our Guest: Dr. Ginette M. Collazo is CEO of Human Error Solutions. She obtained her PhD. in Industrial/Organizational Psychology from the Interamerican University of Puerto Rico. She possesses over 10 years of experience in the pharmaceutical industry with the Technical Training, Organizational Development, and Human Reliability fields. Ginette has worked for Bristol Myers Squibb, Johnson & Johnson, Schering Plough, and Wyeth. She has completed specialized studies in Human Reliability and has authored various publications on this topic. Having implemented Human Reliability programs in various industries, she understands firsthand what works and what doesn't when trying to change a culture from an error-tolerant environment to an error-free learning organization. Ginette has spoken about this topic in numerous professional conferences, including American Institute for Chemical Engineers, the Center for Chemical and Process Safety, the American Society for Quality, Interphex, and FDAnews. Voices in Validation brings you the best in validation and compliance topics. Voices in Validation is brought to you by IVT Network, your expert source for life science regulatory knowledge. For more information on IVT Network, check out their website at http://ivtnetwork.com. For more information on Computer Systems Validation & Software Assurance Week Virtual Event, visit: https://informaconnect.com/it-computerized-systems-validation-csv/?utm_source=IVT%20Network&utm_medium=Podcast&utm_campaign=CBI2833V%20-%20IVT%20Network%20Podcast&utm_content=CBI2833VIVTPodcast&tracker_id=CBI2833VIVTPodcast  

The spot that is now occupied by Earnestine and Hazel’s at 531 South Main St was once the exact opposite of what it was to become in the future. In the late 1800s, it was built as a church, complete with fancy doors and a steeple. The area that the corner building occupies was considered “South Memphis”. It was a residential area that remained so until the early 1900s, when the railroad was built. South Memphis opened two new train stations and 50 passenger cars would come through every day. At that point, the area became able to support businesses. Sadly, the church burned down some time in the early 1900s. I couldn’t find an exact date, but the assessor's office lists the current building’s date as 1918. That year, a new building was erected, the same one you see today, and it was purchased by Abe Plough and turned into one of his Pantaze Drugstores.  Abe Plough is a name synonymous with Memphis. In 1908, he borrowed $125 from his father and started his own business, Plough Chemical Company. He pedaled his “antiseptic healing oil”, that he created in a room above his father’s shop, to the drug stores in and around Memphis. His patent medicine took off and within a couple of years he doubled his profits.  Side note: patent medicines are basically ones that marketed as medicines, but have no proven effectiveness. They are protected by trademarks but their ingredients are generally not completely disclosed. You’ll often hear them referred to as “tonics” or “elixirs”. With his additional money, Plough found his way into the cosmetics and sunscreen business and eventually acquired St. Joseph’s Aspirin brand. Over the next 100 years, Plough Inc became a multi-million dollar company, partnering with Schering Company. Schering Plough and the Plough Foundation became a major philanthropic entity in Memphis.  But let’s rewind. Plough opened Pantaze Drugstores in the 1930s. Apparently Pantaze were the Walgreens of its day. There were 7 Pantaze drug stores on Main St and in the downtown area. It was during his time owning Pantaze that Plough started to expand his brand and continued on to find his fame.  Now in the building on S. Main, Plough only used the bottom floor of the building for his pharmacy/sundry store, so he rented the upstairs to two beauticians, Earnestine Mitchell and Hazel Jones.  Side note: a sundry is basically a general store that sells miscellaneous items One of the products that Plough had made was a hair straightening product and it worked quite well. Not only did the ladies use it in their salon, it was also being used all over the eastern part of the country. With Plough’s success and new found fortune, he gave (or I've also heard sold for a very inexpensive price) the building to Earnestine and Hazel. This transaction occurred some time in the 1950s, from what I can tell.  Having no interest in running a sundry, the ladies decided to turn the downstairs area into a jazz cafe. Earnestine’s husband, Andrew, who went by the name of Sunbeam, opened a venue nearby for musicians, called Club Paradise. This was not the first business venture of Sunbeam Mitchell though. Throughout his years as a promoter, Mitchell had opened several music venues, a restaurant, and even a hotel for African Americans, which were scarce in those times. Earnestine kept the books and ran the hotel.  The Mitchells and Plough were not strangers to each other either. One of Sunbeam’s music venues (Club Handy) and the Mitchell hotel were on the second and third floors of the Pantaze Drugs, which again was owned by Plough, on Beale St. (Wet Willie’s currently occupies this building.)  Club Paradise was the largest and most prestigious nightclub in Memphis. It could hold up to 3200 people. Numerous acts such as locals Bobby Blue Bland, BB King, Howlin Wolf, and Muddy Waters played there, as well as big named acts Ike & Tina Turner, Aretha Franklin, Ray Charles, Chuck Berry, Bo Diddly, & Sam Cook.

“The biggest lessons came from those moments when I failed.” - Rich Robles   Do you think about how you make other people feel? What if you were to focus on just that – how other people feel in your presence?   Failed it! Fam, grab your notebooks, and give a warm welcome to family man and hope dealer, Rich Robles. Rich is a D&I leader at Novant Health, with an impressive background in diversity and inclusion and learning and development. Listen in as he shares his own failure journey through the lens of his professional and personal life. You leave feeling empowered, inspired and in awe of this mans' journey!   In today's episode, Rich tells us all about:   The importance of connecting with your clients at a human level   Exercising empathy as a leader   Giving yourself a break for your own mental health and for your family   Embracing who you really are   Links from show discussions:   Improve it! Online Workshops Connect and engage with Rich on LinkedIn     About the guest: Rich is a senior director of diversity and inclusion at Novant Health.  In his role, Rich leads strategies and work that create a culture where people feel included, engaged and have a sense of belonging while achieving Novant Health's goals.   Rich's background includes both consulting and internal roles in the areas of organizational development, culture transformation, merger integration, and change management. He has led work for companies such as Motorola, PepsiAmericas, McDonald's, Schering-Plough, Chicago Tribune Company, The Spiegel Group, and Exelon.  Rich worked at Bank of America where he held roles responsible for organizational design, culture change, and team effectiveness.  Prior to Novant Health, he was a senior consultant at The Center for Intentional Leadership where he helped clients create high-performing teams and cultures.   Rich received an M.A. degree With Honors in Industrial & Organizational Psychology from Roosevelt University and a B.A. degree in Psychology from Huntington University.   Rich is committed to the Hispanic community in Charlotte, and he has recently been appointed to the Governor's Advisory Council for Hispanic/Latino Affairs. Additionally, Rich is a board member of Urban Promise and The Latin American Chamber of Commerce Charlotte.   Rich grew up in Guatemala City where he attended a military school before moving to the U.S. He resides in Charlotte, North Carolina with his wife and four daughters. In his rare moments of spare time, he enjoys anything related to his favorite soccer team, FC Barcelona, traveling to other countries, and summers at the beach with his family.     About the Host: Erin Diehl is the founder and Chief “Yes, And” officer of improve it! and host of the failed it! Podcast. She's a performer, facilitator and professional risk-taker who lives by the mantra, “get comfortable with the uncomfortable.” Through a series of unrelated dares, Erin has created improve it!, a unique professional development company that pushes others to laugh, learn and grow. Her work with clients such as United Airlines, PepsiCo, Groupon, Deloitte, Motorola, Walgreens, and The Obama Foundation earned her the 2014 Chicago RedEye Big Idea Award and has nominated her for the 2015-2019 Chicago Innovations Award. This graduate from Clemson University is a former experiential marketing and recruiting professional as well as a veteran improviser from the top improvisational training programs in Chicago, including The Second City, i.O. Theater, and The Annoyance Theatre.   When she is not playing pretend or facilitating, she enjoys running and beach dates with her husband and son, and their eight pound toy poodle, BIGG Diehl.   You can follow the failed it! podcast on Instagram and facebook, and you can follow Erin personally on Instagram here. We can't wait to connect with you online!

Jim Joyce and I could have riffed for hours with today's guest on #TheShot of #DigitalHealth Therapy - Jeff Berkowitz, CEO of Real Endpoints. Thanks to Jim, Jeff and I reconnected last summer and today was the day of walking down the memory lane for all three of us:

In Episode 30 of Season 2, Trinity and Mike talk with Ilene Rein an executive recruiter with Marketing and Sales Resources. Ilene also owns Pounding Pavement 101 for job seekers. Ilene talks about the marketing process that goes on within the hiring process. Candidates need a resume that shows results and what they have accomplished. Pleas don't lie on your resume. You will be found out. If you have been out of the work force because you were raising kids, caring for a sick loved one or your spouse gets transferred n a regular, please put that on the resume but also talk about what you did during that time. LINKS AND RESOURCES FROM THE EPISODE https://www.marketingsalesresources.com https://www.poundingpavement101.com MORE ABOUT GUEST Ilene Rein is a Professional Recruiter and Partner at Marketing & Sales Resources, an executive search firm focused on the engineering fields. Ilene developed her coaching program, Pounding Pavement 101, to exponentially increase a job seekers chances of getting noticed and hired rapidly! She shares the inside secrets from the view of the Recruiter and how to grab their attention and become the candidate of choice. Ilene provides seminars, online courses and private consulting to job seekers to develop resumes to generate calls, LinkedIn profiles to create your professional brand, interview preparation and job search strategies. Prior to Ilene's recruiting career, she was a Marketing and Creative Director (Purple Communications, Dolphin Technology, Varityper, PC Magazine) and Corporate Trainer (ExxonMobil, Avaya, Schering Plough). She has always been involved in the hiring and training process in the teams she led. An advocate for the community at large, Ilene is always involved in community events and charities. She is a Mentor for FIRST Robotics and continues to work with FIRST as a judge, volunteer coordinator, planning board member, volunteer, speaker and advisor. THANKS FOR LISTENING Thank you so much for listening to our podcast. If you enjoyed this episode and think others can benefit from it, please share it with them. Do you have any feedback or questions about the episode? Please share with us at info@wired2change.com SUBSCRIBE TO THE PODCAST If you would like to get automatic updates of new Wired2Change episodes, you can subscribe to the ITunes, Stitcher or the podcast app on your mobile device. ABOUT WIRED2CHANGE Wired2Change formed in early 2019 by two people who had nothing in common except the passion to help people. Trinity is from Michigan and got married in 2019. Mike is from Raleigh and is a very happy grandfather. We work with small business owners to put systems and processes in place to help their business become more profitable so they can enjoy the life of a small business owner. CONTACT WIRED2CHANGE www.wired2change.com https://www.facebook.com/wired2change/ https://www.linkedin.com/company/wired-2-change --- Send in a voice message: https://anchor.fm/wired-2-change/message

Ken, through the work of The Vanguard Group for Leadership, helps senior leaders transform themselves and their organizations. Ken helped to lead the transformational turnarounds of Pharmacia, Schering-Plough, and Bausch + Lomb, with a focus on building strong leadership and dynamic new cultures. Connect with Ken: https://www.thevanguardgroupforleadership.com/ https://www.linkedin.com/in/ken-banta-1651946/

Facebook: https://www.facebook.com/thebestmusicpodcast Blog: https://bestmusiccoach.blogspot.com Twitter: https://www.twitter.com/thebestmusicpod Instagram: https://www.instagram.com/thebestmusicpodcast/ The Best Music Podcast #1 | Gregg Hollister | Rock Follies, Living a Creative Lifestyle, Music is its Own Reward Gregg Hollister Gregg's Facebook: https://www.facebook.com/vocalbassdudeGman Gregg Playing: https://www.youtube.com/watch?v=owGAYN6KRh4 The Brian Druxx Project: http://briandruxproject.com/ Gregg has toured recorded or performed with Al Kooper, Richie Havens, Ron Dante, Tommy James, The Rockspurs, Paul Schaefer, Max Weinberg, Bernard Purdie, Phoebe Snow, Ian Hunter, Tico Torres, Joey D, Vicki Sue Robinson, Anthem, Masayoshi Takanaka, Terry Silverlight, Ben E. King, Cory Daye, Tom Verlaine, Paul Schaefer, and Richard Lloyd to name a few. Commercial work includes jingles such as Sony, Kodak, Budweiser, Lifesavers, Mars Candy, Club Med, Yamaha Motorcycles, GM, Ciba Geigy, Schering Plough, and Hertz. TV and film work includes work for PBS the made for TV CBS documentary Julissas Hands (the craigslist killer) movie work such as the Bad Lieutenant and the Driller Killer with Joe Delia/Abel Ferrar and countless musical projects supplying background vocals including Austin Powers movie trailers and Grownups with John Stamos. Gregg can currently be seen and heard playing with Hollister & Friends and The Brian Drux Project. 0:00 Intro 1:46 Warm-Up Questions 4:47 How Gregg Got Into Music 8:55 Rock Follies 1 & The Value of Owning Your Master Recordings 11:50 Perfume Commercials and Bad Contracts 12:55 How Music Publishing Works, How the Money is Divided 16:30 Rock Follies 2 & Managers Stealing from the Band, Getting Robbed 22:41 Joe Delia and the Rockspurs 24:31 Rock Follies 2.5 and 3 26:30 The 80s and Chaka Khan 31:23 The Darryl Canada Project & Rock Follies 4 & What is a Showcase? 34:22 Getting Smart, ASCAP 36:17 What is an Artist Showcase? 38:20 Rock Follies 5 41:56 Phoebe Snow and Al Kooper 45:00 What is a Spec Deal? 47:00 Shopping the Record - Yamaha 51:00 Ben E. King & Background Singer Session Work 52:07 Masayoshi Takanaka 56:00 How Gregg Makes Jingles & Brushing Philip Glass 1:01:30 Music is a Part of Me 1:02:15 Jimmy Leahey, The Brian Druxx Project, Hollister and Friends 1:14:35 Enter Drew Nagal 1:16:14 Max Weinberg Jukebox 1:19:22 Greatest Hits 1:24:20 Lifestyle: Sleep 1:31:54 Lifestyle: Mindfulness and Meditation 1:33:28 How Trans Siberian Orchestra Discovered Ashley Hollister 1:34:54 Paying Your Dues Past vs. Present 1:37:03 Creativity is a Lifestyle 1:40:22 Creativity: The Great Outdoors 1:41:42 Practice: How Many Hours a Day? 1:43:37 Practice: How much Time is Effective? 1:48:05 Performance: Performance Anxiety 1:50:48 Burn out Logo, Intro Video, and Branding: Arron Leishman Audio and Video: Zach Ramey zacherylramey@gmail.com Video Thumbnail: Jean Tomasulo https://www.behance.net/jeantomasulo Dan's Thumbnail Photo: John Mollura Photography

In this episode, I interview Ken Banta Founder and Principal of the Vanguard Group. Ken has distinctly worked in the Life Sciences Industry with Pharmacia & Upjohn and Schering-Plough. He continues to work with CEO's and teams growing capabilities and changing the landscape for leadership in healthcare and life sciences. We dive into the shifts he has seen over the past year in delivery methods for his content as well as some key topics from his Harvard Business Review articles.

We discussed a number of things including: 1. The battle against COVID and the progress on vaccines and treatments 2. The state of innovation in biotech and pharma industries 3. Forecasts for healthcare in 2021 and beyond Fred is a Director with the private equity firm, Warburg Pincus. He is also a Board member of Amgen, Intrexon, Modernizing Medicine, Theramex and Vertice. Fred is the former Chairman of the Board and Chief Executive Officer of Schering-Plough Corporation. Prior to joining Schering-Plough in April 2003, he was Chairman and Chief Executive Officer of Pharmacia Corporation – a company that was formed in March 2000 as a result of the merger of Monsanto and Pharmacia and Upjohn. Hassan joined Pharmacia & Upjohn as Chief Executive Officer in 1997. Previously, Hassan was Executive Vice President of Wyeth, with responsibility for its pharmaceutical and medical products business. He was elected to Wyeth's Board of Directors in 1995. Earlier in his career, Hassan spent 17 years with Sandoz Pharmaceuticals (now Novartis) and headed its U.S. pharmaceuticals business. Hassan received a B.S. degree in chemical engineering from the Imperial College of Science and Technology at the University of London and an M.B.A. from Harvard Business School. Hassan has chaired significant pharmaceutical industry organizations including The Pharmaceutical Research and Manufacturers of America (PhRMA) and The International Federation of Pharmaceutical Manufacturers Associations (IFPMA). Fred's book, "Reinvent - A Leader's Playbook for Serial Success," was published in 2013 by Wiley and has been discussed in many global organizations including the World Bank. In 2014, a CNBC panel named Hassan to a list of those who have had the most profound impact on the world of business in the previous quarter century.

Observe this story of how the FDA actually works, not how most people imagine it works. A 12-year old whistleblower case that sadly is going nowhere How a CEO that leads false marketing of drugs became the Financial Times CEO of the Year “A cardiac arrest in a healthy volunteer had morphed into a fainting episode.” Find out how side effects are downplayed and hidden. The FDA “complicit” with Schering-Plough in criminal activity The sad effects of FDA regulators authoring books with Pharma officers Consultants and businesses that “have a way of overcoming initial regulatory reluctance.” And more Get the references and more at https://healthsovereign.com/61/

Brent Saunders has over 25 years of experience in various aspects of healthcare and has been in leadership roles at several prominent global pharmaceutical and healthcare companies. Until May 2020, when it was acquired by AbbVie Inc. in a transaction valued at approximately $63 billion, Mr. Saunders served as Chairman, President and Chief Executive Officer of Allergan plc. His role as President and Chief Executive Officer of Allergan began in July 2014 and his added role of Chairman began in October 2016. Mr. Saunders first role as an executive officer in the pharmaceuticals and healthcare sectors began in 2003, as a member of the executive management team at Schering-Plough Corporation, where he held several key roles, including President of the company’s Global Consumer Health Care division. While at Schering-Plough, Mr. Saunders led the integrations of the company’s $14 billion acquisition of Organon Biosciences N.V in 2007 as well as the merger between Schering-Plough and Merck & Co., Inc. in 2009. From March 2010 until August 2013, Mr. Saunders served as Chief Executive Officer of Bausch + Lomb Incorporated, a leading global eye health company, until its acquisition by Valeant Pharmaceuticals, Inc. in 2013. He then became the Chief Executive Officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis plc in 2014. Following the merger with Actavis, Mr. Saunders was named Chief Executive Officer of the combined business. In 2015, he led Actavis’ acquisition of Allergan, renaming the combined company Allergan Plc. Learn more about Vesper Health: https://www.vesperhealth.com/ Follow Brent Saunders on Instagram: https://www.instagram.com/brentlsaunders/?hl=en Follow Brent Saunders on Twitter: https://twitter.com/brentlsaunders - Follow me on Instagram: https://instagram.com/casey

Cancer research may yield a potential COVID-19 therapeutic. Dr. Bob interviews Dr. John Rothman of Tyme Technologies about the promising preclinical studies for a new therapeutic. Plus, Kate speaks with Michelle Whitlock, a two-time cervical cancer survivor who had a heart attack in her 40s. She shares the importance of self-advocacy in the doctor’s office.Guest:John Rothman, Ph.D.Executive VP of Product Development, Tyme Technologies Inc. Dr. Rothman has more than 30 years of experience in product development across many disciplines and markets. He was a clinical scientist at the pharmaceutical companies, Schering Plough and Roche, where he was also a clinical director for a number of different therapeutic areas and senior director for all of Roche’s data acquisition, statistical analysis and report writing for all experimental and approved drugs in the Roche portfolio. His work on Interferon-α in AIDs-related Kaposi’s Sarcoma resulted in the approval of the first recombinant drug and AIDS treatment called Referon-A.  Dr. Rothman later held R&D director positions at Roche and was associated with a number of development programs that resulted in marketed drugs, including Rocephin, Coactin, Rimadyl, Larotid, Dalmane, Rimantidine, Gantrisin, Versed, and more. Dr. Rothman was later an executive vice president of science and operations at the biotech company, Advaxis, where he was responsible for R&D, toxicology, regulatory, chemistry, data management, manufacturing, and intellectual property. Dr. Rothman has since held chief executive roles with several biopharmaceutical companies. During his career, Dr. Rothman filed numerous patents and managed a portfolio of over 80 issued patents and patent applications.Hosts:Terry Wilcox, Executive Director, Patients RisingDr. Robert Goldberg, “Dr. Bob”, Co-Founder and Vice President of the Center for Medicine in the Public Interest.Kate Pecora, Field Correspondent  Links:Dr. John RothmanTyme Inc. Tyme’s Oncology Research Reveals Potential New Oral Therapy TYME-19 in the Fight Against COVID-19In ‘Power Grab,’ Health Secretary Azar Asserts Authority Over F.D.A.Patients Rising Concierge Need help?The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.orgHave a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?Drop us a line: podcast@patientsrising.orgThe views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.

 Ralph Kader joined the United Nations (UN) in 1980. Over the next two decades, he rose through the ranks alongside Secretary-General Kofi Annan. He has served in diplomatic missions around the world with six United Nations Secretary-Generals: S-G Kurt Waldheim, S-G Javier Perez De Cuellar, S-G Boutros Boutros-Ghali, S-G Kofi Annan, S-G Ban Ki-Moon, and S-G Antonio Guterres. His missions included Algeria, Iraq, Jordan, and Morocco, among others. As such, he has developed personal relationships with many officials in Muslim countries and the Arab world in both the military and political spheres. He is a personal friend to the current King of Bahrain -- Sheikh Hamad Bin Issa Al Khalifa – as well as other Arab leaders. While at the UN, Ralph was appointed as the special liaison to Algeria and Morocco on behalf of the UN Mission for Peace Keeping Operations to negotiate a peace settlement between the Moroccan and Western Saharan people. His last four posts with the UN were all executive positions as Chief of Information Systems for the Department of Peace Keeping Operations, Military Division. Presently, Ralph is working as a Special Advisor to the Arab States Governments regarding military peace-keeping issues. Ralph has worked for several Fortunes 500 companies, including AT&T, Schering Plough, RJ Reynolds, and Xerox. He holds a Bachelor Degrees in Civil Engineering, Mathematics and Computer Science, and an MBA and a PhD in Information Technology from Central Missouri State University. Ralph is fluent in English and Arabic, and maintains proficiency in French. Visit us at www.bcgfederation.org 

This episode is sponsored by Davwill Consulting Inc. - Looking to review your team?Rob Greenly is a savvy, experienced executive coach and organizational effectiveness consultant. He draws upon twenty years of corporate experience and ten years as a coach and consultant to help his clients maximize their leadership and organizational potential. He applies expertise in leadership coaching, communications, conflict negotiation, team building, performance management, culture & organization change, and training to achieve consistent success for clients. Clients give Rob rave reviews for coaching them—and facilitating their teams—to navigate successfully in large, complex organizations. He draws upon his own firsthand experience as a senior leader and shares lessons-learned from his tenure as Vice President of Leadership and Organization Development—Boston Scientific, Director of OD and Training—Astra Pharmaceuticals, Director of Leadership at the MIT Sloan School of Management, and Chief Administrative Officer for Human Resources—Putnam Investments. Rob has provided executive coaching and/or has developed and delivered programs in management, leadership, team building, organization development, and competency modeling with pragmatic applications, for a wide-range of biopharma/healthcare/medical device clients, including AstraZeneca, Biogen Idec, Covidien, Genzyme, Harvard-Vanguard Medical Associates/Atrius Health, The Medicines Company, Millennium Pharmaceuticals, Novartis Institutes for Biomedical Research, Schering-Plough, and UMass Memorial Medical Center. Also, Rob has coached or consulted to CVS/Pharmacies, General Electric, Harvard University, IBM, Liberty Mutual, Merrill Lynch, National Institutes of Corrections, Northeastern University, the US Navy, and others.Rob's Website - http://www.greenlygroup.com/--- Send in a voice message: https://anchor.fm/deb-crowe/message This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit debcrowe.substack.com

What should your compliance policy and procedures on charitable donations look like? What should you prohibit or even caution against? The starting point is the 2012 FCPA Guidance regarding charitable donations. The information on the red flags from the Opinion Releases and the best practices, as set out in the 2012 FCPA Guidance, have been available for some time. From the Schering-Plough and Lilly enforcement actions, your policy should consider the timing of charitable donations to see if they are at or near the time of the awarding of new or continued business. Finally, in managing the relationship, you now need to look at overall increases in sales to determine if they are tied to a pattern of charitable donations. By looking at the timing and quantum of charitable donations, internal audit may be able to ascertain that a spike in sales is tied to corrupt conduct. Three key takeaways: What are the basic inquiries to make around charitable donations? Use all of the communication tools the DOJ has provided; written guidance, enforcement actions and Opinion Releases to inform your charitable donation policy. “Document, Document, and Document” the basis of your charitable donations risk assessment.

When is a rose not a rose? When it is a charitable donation not made for philanthropic purposes and violates the FCPA. This was a feature of the Eli Lilly and Company (Lilly) FCPA enforcement action brought by the SEC in 2012, involving a bribery scheme utilized by Lilly in Poland. The scheme and FCPA violations mirrored an earlier FCPA enforcement action, also brought by the SEC as a civil matter, rather than by the DOJ as a criminal matter, against another U.S. entity Schering-Plough, for making charitable donations in Poland which violated the FCPA. One of the remarkable things about both of these enforcement actions, brought almost eight years apart, was that they involved improper payments to the same Polish charitable foundation to wrongfully influence the same Polish government official to purchase products from both of these companies.  Three key takeaways: Every compliance practitioner should study both the Lilly and Schering-Plough enforcement actions. What is the purpose of the charitable entity you are making a donation to? “Document, Document, and Document” your due diligence around donors.

This week, I’m talking about 5 mistakes that smart investors don’t make in bear markets. Today, I’m talking about mistake #4 that smart investors don’t make - misunderstanding market cycles.  Understanding the emotions that define market cycles is very important. Market emotions tell you when we’re near or at the top, and when we’re near or at the market bottom. The key is spotting those emotions and taking advantage of it.  Market bottoms are defined by pessimism, followed by panic, followed by capitulation (or surrender). Market bottoms - all of them by the way - are marked by feelings of hopelessness and depression. It’s palpable.  In March of 2009, 18 months into the stock market downturn of the Great Recession, the unemployment rate was still climbing, millions of Americans had already lost their homes, and the stock market had lost half of it’s value.  Yet, on a random day in early March of 2009, the stock market hit bottom and started it’s slow and steady climb for an incredible 11 year run since that time. An article from CNNmoney.com on March 9th, 2009 reads: “Stocks tumbled Monday, with the Dow and S&P 500 ending at fresh 12-year lows, as Merck's $41 billion purchase of Schering-Plough failed to distract investors from worries about the economy….The S&P 500 (SPX) index lost nearly 7 points or 1%, to end at 676.53, its lowest point since Sept. 12, 1996….‘We're seeing more of the same," said John Buckingham, chief investment officer at Al Frank Asset Management. "With an absence of good news, the path of least resistance is down." In this one news article, you can feel the surrender, the hopelessness, the throwing up of the hands in just the simple observation of “well, it’s another down day... just more of the same.” That’s all the commentator had to add that was noteworthy - more of the same.  Yet on this day - March 9th, 2009, the stock market hit bottom, and began one of the greatest and longest bull market runs in history.  When you understand the emotions that define stock market bottoms, you can more clearly see them for what they really are - not more of the same, but an incredible buying opportunity.  That’s it for today, thanks for listening. My name is Ashley Micciche and this is the One Minute Retirement Tip.  ---------- >>> Subscribe on iTunes: https://apple.co/2DI2LSP >>> Subscribe on Amazon Alexa: https://amzn.to/2xRKrCs >>> Check out our blog: https://truenorthretirementadvisors.com/blog/ ---------- Tags: retirement, investing, money, finance, finances, financial planning, retirement planning, saving money, personal finance, wealth management, money tips, fee only financial advisor, financial planner, financial podcast, retirement podcast, financial independence podcast

Janet Shapiro has over 25 years of experience working in public relations, business development, human resources and marketing in pharmaceutical, healthcare, device, non-profit organizations. She has also done work with C-Suite-level, expert cultivation campaigns and authors with diverse disciplines. With a mission to provide top senior-level public relations counsel to corporations and non-profit organizations, Jan has worked both independently and with teams of other senior counselors on a variety of client matters including company and personal branding. Some of her high-profile media placements include features with MSNBC, CNBC, CNN, FOX, TIME, USA Today, US News & World Report, Washington Post, New York Times, Chicago Tribune, Wall Street Journal, Forbes, Fortune Entrepreneur, INC O, The Oprah Magazine, Elle, Self, People, Steve Harvey, and TODAY Show. Corporate clients Jan has worked with include Aventis, Bayer, Schering-Plough, Glaxo -Wellcome, Pfizer, Quest Diagnostics, Kaplan Clinic, Sams Club, Revlon, Colony Group and Masterpiece Living along with over 125 individual personality cultivation campaigns. What you'll learn about in this episode: Jan and Sue's professional journey together The importance of being able to speak out and find support during difficult times What it means to lead with intuition in your personal and professional life Sue's perspective on work-life balance vs. work-life integration How to manage your time as you chase perfection Vision, traction, and health in your organizational success Resources: Website: https://www.smithpublicity.com/ LinkedIn: https://www.linkedin.com/in/janet-shapiro-4591b152/ https://www.linkedin.com/company/smith-publicity-inc./ Facebook: https://www.facebook.com/SmithPublicity Twitter: @SmithPublicity The Unf

Are you dealing with toxic or negative emotions due to a breakup or divorce?  Maybe you feel like you're in the midst of a nuclear meltdown or trauma because a contentious divorce or nasty divorce tactics are bringing you down.  This week Rebecca Zung talks with Jennifer Giamo, celebrity personal trainer you've seen on Live with Ryan and Kelly and Rachael Ray as a regular guest.  In this riveting and very personal episode, Jenn gets so real and so raw, sharing:  1.  How her divorce flattened her to the point that she couldn't get out of bed 2. The humiliation of dealing with her husband leaving her and it being in the tabloids  3. How despite her life looking shiny, perfect and beautiful, she still struggles with toxic head trash  4. How creating Fresh Start Fitness has helped her save lives of thousands of women dealing with a brutal divorce, but actually helped her save herself too.   5. Who her "go-to" authors and mentors are.  6. How she learned to release toxic emotions and step by step created her own journey to recovery.   7.  How she learned to survive and thrive by creating a network of supportive women.   More about Jenn Jennifer is an NSCA Certified Personal Trainer with a Master's Degree in Nutrition Education, and the founder of Trainers in Transit LLC. Jennifer started the company in 2010 after leaving her career in Corporate Fitness & Wellness where she was a managing director for multiple Corporate Fitness Centers throughout New York City and the Northeast region. Jennifer's experience in the field spans over 15 years; she has worked with corporate clients such as IBM, Johnson & Johnson, Schering-Plough and Dow Jones. Jenn was a running coach with Team in Training Leukemia & Lymphoma Society and has personally finished 7 marathons.  Jennifer specializes in HIIT-style workouts, endurance training and corrective exercise. She assists clients working with their physical therapists, chiropractors and doctors in the rehabilitation and recovery from various types of injuries. She also works closely with clients looking to improve their eating habits, seek guidance regarding special diets, or are simply trying to understand the role of nutrition to meet their fitness goals. She has recently become a Certified Reiki Practioner and is excited to offer this new (age) service to her clients! Additionally, Jenn has on-camera, television experience (Live with Kelly & Ryan and Rachael Ray) and currently teaches classes for the producers of ABC-TV. Jenn's passion for writing has also earned her 4 published articles on ThriveGlobal.  ______________________________________________________________________________________ For more information on REBECCA ZUNG, ESQ. visit her website www.rebeccazung.com and follow her on Instagram: @rebeccazung and YouTube! GRAB YOUR FREE CRUSH MY NEGOTIATION PREP WORKSHEET RIGHT HERE!  SUBSCRIBE TO MY YOUTUBE CHANNEL RIGHT HERE.  HOT NEWS! Make sure to grab a copy of Rebecca'a BRAND NEW BOOK, Negotiate Like You M.A.T.T.E.R.: The Sure Fire Method to Step Up and Win (foreword written by Robert Shapiro).  It went straight to being a #1 bestseller the first day it was launched! Find out what everyone is so excited about - get the book RIGHT HERE!  To get your copy of Rebecca's bestselling book, Breaking Free: A Step by Step Guide to Achieving Emotional, Physical and Spiritual Freedom, please visit the Amazon website to order it RIGHT HERE.     Rebecca also is available for keynote speeches, and speaks around the country on "How to Successfully Negotiate With a Narcissist" and "Win Any Negotiation in Just 6 Steps". Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you dealing with toxic or negative emotions due to a breakup or divorce?   Maybe you feel like you're in the midst of a nuclear meltdown or trauma because a contentious divorce or nasty divorce tactics are bringing you down.   This week Rebecca Zung talks with Jennifer Giamo, celebrity personal trainer you've seen on Live with Ryan and Kelly and Rachael Ray as a regular guest.   In this riveting and very personal episode, Jenn gets so real and so raw, sharing:  1.   How her divorce flattened her to the point that she couldn't get out of bed 2.  The humiliation of dealing with her husband leaving her and it being in the tabloids  3.  How despite her life looking shiny, perfect and beautiful, she still struggles with toxic head trash  4.  How creating Fresh Start Fitness has helped her save lives of thousands of women dealing with a brutal divorce, but actually helped her save herself too.   5.  Who her "go-to" authors and mentors are.  6.  How she learned to release toxic emotions and step by step created her own journey to recovery.   7.   How she learned to survive and thrive by creating a network of supportive women.   More about Jenn Jennifer is an NSCA Certified Personal Trainer with a Master's Degree in Nutrition Education,and the founder of Trainers in Transit LLC.Jennifer started the company in 2010 after leaving her career in Corporate Fitness & Wellness where she was a managing director for multiple Corporate Fitness Centers throughout New York City and the Northeast region. Jennifer’s experience in the field spans over 15 years; she has worked with corporate clients such as IBM, Johnson & Johnson, Schering-Plough and Dow Jones. Jenn was a running coach with Team in Training Leukemia & Lymphoma Society and has  personally finished 7 marathons.  Jennifer specializes in HIIT-style workouts, endurance training and corrective exercise. She assists clients working with their physical therapists, chiropractors and doctors in the rehabilitation and recovery from various types of injuries. She also works closely with clients looking to improve their eating habits, seek guidance regarding special diets, or are simply trying to understand the role of nutrition to meet their fitness goals.  She has recently become a Certified Reiki Practioner and is excited to offer this new (age) service to her clients! Additionally, Jenn has on-camera, television experience (Live with Kelly & Ryan and Rachael Ray) and currently teaches classes for the producers of ABC-TV. Jenn's passion for writing has also earned her 4 published articles on ThriveGlobal.  ______________________________________________________________________________________ For more information on REBECCA ZUNG, ESQ. visit her website www.rebeccazung.com and follow her on Instagram: @rebeccazung and YouTube! GRAB YOUR FREE CRUSH MY NEGOTIATION PREP WORKSHEET RIGHT HERE!  SUBSCRIBE TO MY YOUTUBE CHANNEL RIGHT HERE.  HOT NEWS!  Make sure to grab a copy of Rebecca'a BRAND NEW BOOK, Negotiate Like You M.A.T.T.E.R.: The Sure Fire Method to Step Up and Win (foreword written by Robert Shapiro).   It went straight to being a #1 bestseller the first day it was launched!  Find out what everyone is so excited about - get the book RIGHT HERE!  To get your copy of Rebecca's bestselling book, Breaking Free: A Step by Step Guide to Achieving Emotional, Physical and Spiritual Freedom, please visit the Amazon website to order it RIGHT HERE.      Rebecca also is available for keynote speeches, and speaks around the country on "How to Successfully Negotiate With a Narcissist" and "Win Any Negotiation in Just 6 Steps". **************************************************************** CONTACT US:  rebecca@rebeccazung.com WEBSITE:   www.negotiateyourbestlifepodcast.com ........................................................................................................................ Remember to follow THE NEGOTIATE YOUR BEST LIFE PODCAST on social media for updates and inside tips and information: Instagram If you want to see the video version of the podcast episodes they are available on Rebecca's YouTube (make sure to LIKE and SUBSCRIBE so you don't miss a single episode). Finally, we'd really appreciate it if you would visit iTunes and give us a 5 Star Rating and tell us what you like about the show - your feedback really matters to us! DISCLAIMER:  THE COMMENTARY AND OPINIONS AVAILABLE ON THIS PODCAST ARE FOR INFORMATIONAL PURPOSES ONLY AND NOT FOR THE PURPOSE OF PROVIDING LEGAL ADVICE.  YOU SHOULD CONTACT AN ATTORNEY IN YOUR STATE TO OBTAIN LEGAL ADVICE WITH RESPECT TO ANY PARTICULAR ISSUE OR PROBLEM.    

Palestrante, engenheiro e piloto conhecido por liderar a equipe que conquistou 18 pódios durante os 25 anos que representou o Brasil no Rally Dakar. Com nossa equipe já realizou mais de 1.000 trabalhos (palestras, atividades experienciais, team building e treinamentos) para empresas como Abbott, Alcoa, Arthur Andersen, Aventis, BB, Bradesco, Itaú, Santander, Basf, Bosch, BRF, Bunge, Citroën, Claro, Coca-Cola, CVRD, Duratex, E&Y, Embratel, Faber Castell, FGV, Ford, Gerdau, Gessy Lever, Grupo Algar, HP, IBM, Janssen Cilag, Kraft, Lenovo, Lojas Pernambucanas, Mahle Metal Leve, Mercedes-Benz, Monsanto, Nestlé, Novartis, Oracle, Pão de Açúcar, Petrobras, Pirelli, Porto Seguro, P&G, Redecard, Renault, Rhodia, Roche, Saint Gobain, Samsung, Santista Têxtil, Schering-Plough, Shell, Siemens, Sony Ericsson, Sul América, Sun, Syngenta, Telefônica, Ticket, Tigre, TIM, 3M, Unilever, Vivo, Volvo, Votorantim, VW, além de escolas e universidades, e muitas outras empresas. Suas participações estimulam o protagonismo e o trabalho em equipe, em benefício da velocidade com responsabilidade, do planejamento que viabilize a eficácia consistente. Nós encorajamos a resiliência e o estabelecimento de um ambiente de confiança. O objetivo é colaborar no desenvolvimento de habilidades como: 1. Pensamento crítico e resolução de problemas; 2. Adaptabilidade e flexibilidade; 3. Comunicação; 4. Liderança; 5. Inovação e criatividade. Realiza consultorias e participo de projetos que utilizam energias renováveis, dentro e fora das pistas. Escreveu três livros: - Rally Paris-Dakar – O Vírus do Deserto, - Grãos de Areia – 8 anos de aventuras no Rally Paris-Dakar, - Rali – Abrindo os caminhos do Brasil. Também tem participação em outros livros e escrevo artigos para revistas, jornais e sites na internet. Comentarista dos canais esportivos da ESPN desde 2007, com blog no site da ESPN Brasil 

You ,Too, Can Have Your Healing Miracle with Todd Laure and Marcel Herbst Todd Louer is an entrepreneur and the co-founder of GLO Industries, based in Delray Beach, Florida. He received his B.S. in Advertising from the University of Florida before going into the corporate sales world with organizations like Phillip Morris USA, Schering Plough, and Glaxo Smith Kline. After spending five years working for someone else, Todd turned in his corporate card and began chasing his lifelong dream of owning and operating his own business in the marketing /sales space where he has been ever since. His passion is people, and he enjoys taking on private clients for business/life coaching. In his coaching practice, Todd uses his foundation in emotional intelligence work that he credits for changing his own life and business for the better. He currently resides in Delray Beach, Florida, with his girlfriend Rebekah and his dog Louie.    Marcel Herbst is Managing Member of Elgin Crescent, LLC, a NY-based capital advisory firm.  Marcel received an M.B.A. from the University of St. Gallen, Switzerland in 2001    From 2017 to 2018, he was Partner and Head of Capital Formation at Acceleration Resources, a San Francisco-based energy private equity firm backed by an institutional $50b   .   He is also a board member of the rBaby Foundation and recipient of the “rBaby Hero Award” of 2013.  Marcel is married and has two children. Marcel had a stroke in 2009 and has been monitoring his brain health ever since. IN August 2019, Marcel spent a week at Rythmia Life Advancement Center and upon his return found the his MRI had no sign of any brain damage. This s the fist time since his stroke that his MRI was clear!   For more information about Rythmia Life Advancement Center, please go to rythmia.com/sellman or call ‭(844) 346-8069. My next group trip will be the week of Feb. 9, 2020.  Please contact me  ( drs@drsherrillsellman.com) or Rythmia to be eligible for the special discounted price - only available for my group for that week. Be ready for your miracle!  

Dr. Don Kennedy is a board certified family physician, author, professor, lecturer, and certified coach. He is the recognized world expert on longevity and smoking cessation and his unique Smoking Bahbit™ program has helped hundreds beat nicotine addiction. He has practiced family and geriatric medicine for twenty five years Dr. Kennedy is a Diplomat of the American College of Family Medicine, holds a Masters in Business Administration degree from Stetson University, He has been a staff writer for Life Now magazine and has spoken for companies such as Merck, Schering-Plough, Younglife, Rotary International, and Pfizer. His radio show, You Are the Doctor, was the first interactive programs of its kind . His delightful new book, 5 AM & Already Behind, was written to teach the need to change now, not later. It is a story about Mike and uses a workbook format to teach us the Bahbit™ system Dr. Kennedy has used it to create immediate change and improve the health of thousands of patients.

Attorneys Christopher Major and Greg Lois present a webinar on carrier recovery through reimbursement and subrogation under New Jersey's Section 40 (N.J.S.A. 34:15-40). They discuss the impact of recent cases, such as the December 11, 2017 Supreme Court decision in Vitale v. Schering Plough and the November 22, 2017 Appellate Decision in Pino v. Polanco. The attorneys discuss reimbursement to the carrier/employer from the proceeds of civil actions as well as tactics for maximizing recovery - including practical negotiation tips for dealing with plaintiff's attorneys who always demand a lien reduction to "1/3rd.

Show description/summary:1) Functional impairments for outcomes in a randomized trial of of unruptured brain AVMs2) What’s Trending: Hurricane Harvey and patient care in TexasThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the October 3, 2017, issue of Neurology. In the first segment, Dr. Andrew Southerland talks with Dr. JP Mohr about his paper on functional impairment outcome measurements in a randomized trial of unruptured brain arteriovenous malformations. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Aziz Shaibani on Hurricane Harvey and its effect on patient care in Texas. Disclosures can be found at Neurology.org.DISCLOSURES: Dr. Southerland serves as Podcast Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review.Dr. Mohr serves as Associate Editor for History of Stroke and Cerebrovascular Disease; has consulted for Schering-Plough; has given expert testimony on unruptured brain AVMs; and has received research support from NINDS associated with the ARUBA trial. Dr. Crowell reports no disclosures.Dr. Shaibani is President-Elect for the Texas Neurology Society.

  Lorrie Carr joined ZappRx in April 2016 as Chief Commercial Officer. She has over 20 years' experience in the health care industry – primarily focused in the pharma/biotech and specialty pharmacy industries. Just prior to joining ZappRx, Ms. Carr was the Divisional VP of Enterprise Specialty Sales and Product Management for Walgreens Specialty Pharmacy. Ms. Carr transformed the strategy, operations and deployment of the over 300-person Specialty and Infusion sales teams resulting in consistent double-digit year over year growth for the multi-billion-dollar business. In addition, she created, built and successfully led the product management team which developed and executed on growth strategies for high priority specialty disease areas. Prior to Walgreens, Ms. Carr was the Head of U.S. / Global Market Access for Millennium Pharmaceuticals (now Takeda Oncology) where she built the first Reimbursement & Market Access team for the company, advised global R&D on access related trial design decisions, led the European patient access strategy, and played a material role in developing pricing, contracting, distribution and patient assistance program strategies for pipeline and marketed products. She started her pharmaceutical career at Schering-Plough (now Merck) where she held various roles in account management, and ultimately, became a senior leader of the US Market Access marketing group. Ms. Carr received her Bachelor's degree from Columbia College and holds her MBA from UMASS Isenberg School of Management. 00:00 Specialty Pharmaceutical Products. 02:30 Inefficiencies in the system. 04:00 The paper-fill process for Patient Prescription/Enrollment with Specialty Pharmacies. 06:30 Enrollment Forms for prescription drugs filled at Specialty Pharmacies. 10:20 The overwhelming cost and administrative overhead for Providers having to keep track of all of these forms. 13:00 How the process changes for Providers with ZappRx 19:00 Getting the drug out to the patient without conflict. 20:00 Double check for patients and Specialty Pharmacy. 22:00 Why ZappRx is collaborative, not competitive. 23:30 ZappRx's work on the Provider side. 24:25 Gathering Data at the front-end of the prescribing process. 25:15 ZappRx's long-term business model. 25:30 Missing Data in the healthcare and pharmacy markets. 27:45 Aggregating data and identifying trends. 28:30 ZappRx's five key focus Disease Areas. 30:00 You can learn more about ZappRx at www.zapprx.com.

David Chitel is an industry leader in the New Generation Latino media and entertainment space. Along with founding partner, actor John Leguizamo, in 2001 David created one of the first Latino social networking communities, iCaramba.com.  Over the next 5 years, David evolved parent company, LatCom Communications, into a leading 360 degree integrated service provider helping Fortune 500’s reach New Generation Latinos through live events, magazines, online and college campus marketing.  In 2006, he sold LatCom to Batanga Media, a leading online Latin music destination and online network.  Concurrently, David founded and chaired the New Generation Latino Consortium (NGLC.biz), an organization dedicated to hosting business conferences and fielding innovative research studies focused on the NGL audience.  He also served as creator, writer, and producer of the first Latino animated TV series, ‘Lugar Heights’, which aired on mun2 and later on MTV-Tr3s and as a full-length DVD. David’s career began at SiboneyUSA Hispanic advertising where he successfully served as Director of Client Services and New Business on such accounts as Colgate-Palmolive, U.S. Postal Service, Tropicana, Schering-Plough, Banco Popular and others. David's current venture, NGL Media (NGLMedia.com), provides Latino video marketing solutions for advertisers looking to reach and engage digitally-connected Latinos across platforms.  He lives in New York City with his wife and two kids who are “Spanglish-dominant.”  David holds a B.A. in Philosophy with a Spanish minor from Boston University. What you'll learn David's fascinating entrepreneurial journey in the Latino media and entertainment world, don't miss it ! Resources & Links email: dchitel@nglmedia.com Nglmedia.com Do you have a dream and the drive to pursue it but lack the roadmap, the inspiration and the access to Latino role models that show you that it is possible? Enter “Logra Tu Dream” a book that will show you how 50 successful Latinos & Latinas turned their dreams into reality and how you can too. Get your book here NOW: logratudream.com/amazonreview Click Here to Subscribe//

http://www.PlayGolfLikeThePros.com founder US Junior Team Coach and #1 Best Selling Golf Author Gary Occhino interviews Tara Frier Founder and CEO of Goodwin Group PR brings to her firm more than 25 years of media relations, public affairs and public policy experience. Frier oversees the strategic direction of all client accounts and over the years has worked with large and small companies to increase visibility, create demand for products and services and grow bottom lines. Whether planning a large corporate event or navigating a client through the uncharted waters of a crisis situation, Frier is known as a leader who provides open and honest counsel and helps clients develop the infrastructure to sustain successful communications programs. Before starting the company, she served as Vice President of Edelman Public Relations’ Boston office where she managed an active portfolio of clients, and executed Boston media strategies for Edelman’s national and international accounts including: IDA Singapore; Barnes & Noble; Belgian energy company, Tractebel, Inc.; Schering-Plough; Morgan Stanley; JAFCO Ventures and YouthBuild U.S.A. Frier was also the lead strategist for the state’s education reform (MCAS) campaign. Her contributions to Barnes & Noble’s Close the Book on Hate campaign helped Edelman score a Silver Saber award for best retail marketing initiative. She was named one of Boston’s Top 10 PR specialists in 2006 and 2009 by Women’s Business Boston. Prior to her work at Edelman, Frier served as chief of staff of the Massachusetts Department of Housing and Community Development where she managed a staff of 250 and a budget of $450 million. In addition, she worked to develop an affordable housing policy designed to help alleviate the Massachusetts housing crisis, wrote and edited all agency RFP’s, managed contractors and served as a member of the Governor’s Commission on Domestic Violence. She was named one of Women’s Business Boston’s “Top 10 PR Specialists” in 2006 and 2009 and was a 2011 nominee for PR Person of the Year by Biz Bash

Dr. Don Kennedy is a board certified family physician, author, professor, lecturer, and certified coach. He is the recognized world expert on longevity and smoking cessation and his unique Smoking Bahbit™ program has helped hundreds beat nicotine addiction. He has practiced family and geriatric medicine for twenty five years Dr. Kennedy is a Diplomat of the American College of Family Medicine, holds a Masters in Business Administration degree from Stetson University, He has been a staff writer for Life Now magazine and has spoken for companies such as Merck, Schering-Plough, Younglife, Rotary International, and Pfizer. His radio show, You Are the Doctor, was the first interactive programs of its kind . His delightful new book, 5 AM & Already Behind, was written to teach the need to change now, not later. It is a story about Mike and uses a workbook format to teach us the Bahbit™ system Dr. Kennedy has used it to create immediate change and improve the health of thousands of patients.

Guest: John Kreger Host: Bruce Japsen News of mega-mergers involving the likes of Pfizer and Wyeth or Merck and Schering Plough have turned the pharmaceutical industry on its ear. But what does this mean for you and your patients? John Kreger, a principal with the health care investment bank William Blair & Company, tells the Chicago Tribune's Bruce Japsen about how consolidation among drug companies could impact doctors and their patients.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jim Kiely and Dr. Shanna Patterson interview Dr. Schiff about his paper on low-grade glioma. The podcast concludes with Dr. Lori Schuh interviewing Dr. Jennifer Quinn for the Lesson of the Week. Podcast participants had nothing to disclose except for Dr. David Schiff who has given lectures through the Schering-Plough Speaker's Bureau and served as a consultant to Schering-Plough.